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The development and identification of new biomaterials that can replace specific 
tissues and organs is desirable. In the presented PhD thesis polymer microarrays 
were applied for the screening of polyacrylates and polyurethanes and evaluation for 
material discovery for applications in the life sciences. 
In the first part of the thesis, the largest polymer microarray ever made with more 
than 7000 features was fabricated and subsequently used for the screening of 
polyacrylates that can control the fate of human embryonic stem cells. As stem cells 
have unique properties that offer the potential of replacing damaged or diseased 
tissue in future, the identification of cultivation substrates that can replace current 
biological and animal derived products was desirable. The water contact angle, 
roughness and cell doubling time of the cells on the identified polymers was 
determined and the stem cells characterised after 5 passages and compared to the 
currently most widely used animal derived substrate Matrigel
TM
. 
In the second part of the thesis, the development of a new polymer gradient 
microarray is presented. Initial studies involved the optimisation of printing 
parameters for the generation of linear polymer gradient lines and confirmed by XPS 
analysis. Cellular binding studies with the suspension cell line K562 and the adherent 
cell line HeLa were carried out and compared to previous binding studies to confirm 
the success of the concept. In further studies, the polymer gradients were 
functionalised with small molecules and proteins, allowing the generation of a 
protein gradient microarray with Semaphorin 3F. In binding studies with neuron cells 
it could be shown that the binding of the cells was concentration-dependent. 
The identification of polyacrylates for the effective and rapid activation and 
aggregation of platelets is described in the third part of the presented thesis. Here, 
polymer microarrays were applied for the binding of platelets in human blood 
samples. The amount of bound platelets as well as their activation state was 
compared to the natural agonist collagen by employing fluorescence intensity studies 
and scanning electron microscopy. In shear studies, the activation of the platelets by 
the polymers was evaluated under physiological conditions. The mechanism by 
which the polymer triggered the activation was further explored by protein binding 
studies. It was shown that the initial adsorption of fibrinogen and von Willebrand 
factor on the polymers lead to the adherence and aggregation of platelets.  
In the final part of the presented thesis, polymer microarrays were used to identify 
polymers that can sort and collect the precursor cells of platelets (megakaryocytes). 
For this purpose, the cell lines K562 and MEG-01 were used as cellular models. The 
identified polymers and the effect on the immobilised cells was further investigated 
by scanning electron microscopy, flow cytometry and miRNA studies. The adsorbed 
proteins on the different polymers were found to influence the cellular morphology 
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Chapter 1: Introduction 
 
1.1 Biomaterials and Biocompatibility 
In general, biomaterials are characterised by their ability to coexist in close contact 
with body tissue without causing an unacceptable degree of harm.
1
 The most recent 
definition by David F. Williams describes biocompatibility as the following: 
“Biocompatibility refers to the ability of a biomaterial to perform its desired function 
with respect to a medical therapy, without eliciting any undesirable local or 
systematic effects in the recipient or beneficiary of that therapy.”
2 
Such materials are not a recent innovation as over 2000 years ago, biomaterials such 
as gold, silver and wood were used as substitutes for body parts.
3 
Over the last 
century, new ceramics, metals and polymers have been designed which display well 
defined mechanical, chemical and biological properties such as mechanical strength, 
corrosion resistance and biodegradibility. This large portfolio of properties of today’s 
biomaterials offer the chance to tailor them towards the application in unique 
biological environments and their application in complex, diverse areas such as 









Normally, there are several characteristics that are combined by a perfect biomaterial 
when being implanted into the host: 
 Lack of cytotoxicity towards the host (biosafety) 
 Fulfillment of required material-tissue interactions (promotion or inhibition) 
 Minimal immune response and inflammation 
 Optimal chemical, physical and mechanical properties (such as strength, 
stress- and pressure endurance).
4,8
 
Since biocompatibility is a complex mechanism which is still not predictable, the 
investigations of the processes after a biomaterial is placed into a host (foreign body 
responses) are very important.
8,9
 In this context, blood-material interactions are the 
most prominent ones which lead to a complex series of events that are highly 
interlinked (Figure 1.1).  
 




Haemostasis                                                    Inflammation 
3 
 
In the first step after implantation, proteins and peptides adsorb onto the surface of 
the foreign biomaterial. These molecules mediate the binding and activation of cells 
such as monocytes, leukocytes and platelets. The coagulation cascade and the 
complement cascade are triggered, resulting in haemostasis and inflammation 
reactions.
9
 The level of these responses depend strongly on the transplanted 
biomaterial and determine whether the material is tolerated or leads to complications 
and/or rejection.  
Depending on the transplanted device, the risk of thrombotic complications varies 
between 2-10%.
9
 However, it is still unknown how much of an inflammatory and 
thrombosis response is tolerable for a person. Furthermore, small diameter vascular 
grafts cannot be introduced to the human body as the resulting thrombogenicity is too 
high. Hence, surface modifications of already used devices or completely new 
biomaterials that reduce further host responses are desirable.
9 
 
1.2 High-throughput Screening of Biomaterials 
High-throughput screening (HTS) of materials is defined as a methodology which 
identifies suitable materials for a certain purpose by screening a large compound 
library.
10
 It is a powerful tool when the correlation of performance and the theoretical 
predictions of the performances from the structure and composition of a molecule, 
formulation or material is poor. This is the case for biomaterials, where the complex 






1.2.1 Microarrays as Tool for HTS 
Microarrays are high-throughput tools that consist of a flat material (e.g. glass or 
silicon) on which numerous probes are deposited in a defined and known 2D 
grid.
11,12
 Each feature can be seen as a single independent assay, which can be 
replicated and which allows the whole assay to be carried out under identical 
conditions with minimal amounts of probe material.
13,14 
Today, microarrays are 
widely used in biological areas and have given rise to commercially available DNA 
and protein arrays.
14,15
 Depending on the intended application of the microarrays, the 
substrate on which the probes are deposited as well as the deposition technique have 
to be carefully chosen. In Table 1.1 a brief overview of the frequently used 
substrates, surface modifications and probe deposition mechanisms are given.  


































1.3 Printing Techniques 
For the deposition of different probes on a substrate, a variety of printing techniques 
have been developed that can be divided into contact and non-contact printing 
methods.
27
 In the first case material is deposited by direct physical contact of the 
substrate with an inked stamp of some type, while non-contact printing techniques 
avoid any type of contact with the substrate. Here, the ink is dropped onto the 
substrate in a very precise manner. In general, contact printing systems are simpler in 
design, faster and less expensive. Non-contact instruments allow printing on more 
fragile substrates and enable more flexible printing designs. 
 
1.3.1 Contact Printing Approach 
In the contact printing approach, features are generated by a high precision X-Y-Z 
robot holding pins that dip into the compound solution (ink) and dispose it at a 
specific site by physical contact.
28
 The chemical and physical properties of the pin, 
solution and the substrate as well as the printing parameters of the robot (speed, 
number of depositions) affect the printing quality. In particular, the wettability of 
substrate and pin as well as the viscosity and surface tension of the liquids have an 
influence on the uniformity and amount of deposition. External factors like humidity 




There have been a range of different pins developed to optimise the printing of 




Figure 1.2: Different types of pins used in the contact-printing approach. a) Solid 





Solid pins are plain needles (Figure 1.2a), which are robust and give an excellent 
spot-size reproducibility. The size of the created spot can be varied by changing the 
pin diameter and with it the amount of liquid which is transferred. The disadvantage 
of solid pins is that the ink only lasts for one print - they have to be washed and 




Split and Stealth pins  
The pins are characterised by having a narrow slit and cavity in the centre of the 
needle which enables the print of several hundred spots after a single load (Figure 
1.2b).
30,31
 These pins are the most widely used in the biological section. A pre-
blotting step is required to guarantee a uniform spot deposition, which is also 
depending on the slit width and slit inclination. The printing environment has to be 
adjusted to keep sample evaporation at a minimum by e.g. controlling the humidity 
in the printer casket.
31 
Split and stealth pins are not suitable for the deposition of 
viscous material such as polymer solutions that might block the split pin.  




Ring and pin system 
In this system a liquid film is generated by dipping a ring into the ink-well and 
removing it. A liquid film is captured in the ring, through which the solid metal pin is 
moved. The ink is deposited onto the substrate without disrupting the liquid film 
(Figure 1.2c).
32
 The film serves as reservoir, allowing multiple prints of the same 
solution. During these prints, temperature and humidity have to be controlled to 




The combination of traditional photolithography to form a very precise stamp and the 
contact-printing technique to transfer the ink in a fast and effective manner gave rise 
to microcontact printing. This technique allows patterning of large surface areas with 
resolution down to the submicrometer range.
34,35
 The stamp is often generated as 
shown in Figure 1.3.
36
 In the first step a template (master) is created on silicon. After 
applying a light-sensitive material (photoresist), UV irradiation through a photomask 
generates local reactions on the photo-sensitive material. After baking, developing 
and removing the non-irradiated areas of the substrate, the master can be used to 
generate a polydimethylsiloxane (PDMS) stamp, whose elevated areas correspond to 






Figure 1.3: Microcontact printing. a) The master is fabricated by irradiation of the 
photoresist through a mask, generating a precise mould. b) The mould is used as 
template for polydimethylsiloxane (PDMS). c) The photoresist is peeled off to obtain 
the master. d) After inking and applying the stamp onto a substrate via physical 




After the stamp is peeled off, it can be used for inking (Figure 1.3). The ink can 
thereby diffuse into the bulk of the stamp material, allowing the creation of a rink 
reservoir for multiple prints. By direct physical contact of the stamp and the 
substrate, the ink is transferred to the substrate. As the stamp can be easily deformed, 















1.3.2 Inkjet Printing Approach 
The main advantages of inkjet printing approaches over contact printing are the 
gentle deposition (allowing the printing on fragile substrates), better control of 
deposition (enabling the printing of a wider range of spot sizes), while the accurate 
movement of the nozzle makes it possible to print complex patterns and grids.
39
 
There are three different technologies used in the inkjet printing approach: thermal, 
piezo and solenoid methods (Figure 1.4). 
 
 
Figure 1.4: Inkjet printing techniques. Thermal, piezo and solenoid jets and the 




Thermal jet  
In the thermal or bubble jet a resistive element in a small chamber containing the ink 
is rapidly heated. The high temperature (350-400 °C) vaporises a thin film of ink 
above the heater and the resulting bubble forces the ink out of the nozzle. The void in 
the chamber after the ejection of the drop, is filled by replacement fluid afterwards.
40
 
The advantages of this technology are the generation of very small drop sizes and 
10 
 
low printhead costs. However, thermal jet printers are limited to the inks which can 
be used. Normally these systems are optimised for certain ink compositions that are 
aqueous or part-aqueous as they allow an easy vaporisation.
40
 While the printing 
principle is used in desktop printers, there is no commercial available industrial 
microarrayers based on this method. However, scientific research groups have 
modified normal desktop printers for the delivery and patterning of (bio)molecules.
41 




In the piezo inkjet printer a pressure wave is used to eject droplets from the nozzle. 
The pressure is generated by a rapid dimensional change of the piezoelectric material 
(usually lead zirconium titanate). The amount of deposited ink is controlled by the 
duration and amplitude of the applied voltage to the piezo material.
40
 Hydrophobic 
and hydrophilic coatings of the nozzle can also improve the printing results 
depending on the characteristics of the ink.
43
 In contrast to thermo jets, the piezo 
inkjet technology is not limited to certain inks and is equipped with printheads that 
have a long life (if no mechanical damages occur). However, since the printheads are 
relatively expensive, the piezo jet is classified as high cost technique.
40,42 
A 
combination of the piezo technology with heated nozzles can also be applied for the 





In this printing method, a pressurized liquid in a nozzle is dispensed by the quick 
opening and closing of high speed valves, which are electrically controlled. The 
11 
 
volume of the deposited material depends on the applied pressure within the nozzle, 
the viscosity of the fluid, the nozzle dimensions and the pulse width controlling the 





1.4 Types of Microarrays  
1.4.1 DNA Microarrays 
Microarrays of known oligonucleotides or DNA sequences are used to measure the 
expression levels of genes, to detect single nucleotide polymorphisms and mutations 
or to genotype regions of a genome amongst multiple others.
46-50
 The principle of 
DNA microarrays is based on the specific pairing of complementary nucleic acid 
sequences through the formation of hydrogen bonds. A higher percentage of 
complementary nucleic acids results in a stronger binding of DNA strands for the 
correct sequence rather than a mismatch. After hybridization of the genetic material 
onto the arrays, non-specific binding sequences are washed off, leaving the 
fluorescently labelled complementary DNA (cDNA) strands behind. The fluorescent 
intensities from each spot give the identity and the relative amount of the 
immobilised probes. DNA arrays have been used to examine changes in gene 
expression in case of diseases such as cancer and are useful tools for the 






1.4.2 Protein Microarrays 




Analytical microarrays consist of an immobilised library of antibodies or aptamer 
and are used to profile protein mixtures. They allow the investigation of the binding 
affinities and protein expression levels of the different proteins.
53,54
 Hence, they can 
be used as diagnostic tools by profiling the different expression patterns of proteins 
and comparing the results between healthy and disease tissues.
55 
 
Functional protein microarrays consist of full-length proteins/ protein domains that 
are deposited. They are applied for the investigation of protein-protein, protein-DNA, 




1.4.3 Polymer Microarrays 
To identify suitable polymers for certain applications in a rapid and effective manner, 
polymer microarrays were independently invented by the research groups Langer, 
Voelcker  and Bradley.
20,21,58-60 
 
Langer Approach  
The research group of Langer focuses on the generation of polymer microarrays for 
cellular applications using poly(hydroxyethyl methacrylate) (pHEMA) dip-coated 
microscope slides as a cytophobic basis for the polymer probes. The coating prevents 
any cell attachment while being non-toxic and allowing printed material “to 
penetrate in the matrix where the material can physically entangle”.
21,61
 The polymer 
13 
 
features are either pre-synthesised or are in situ synthesised on the slide by using a 
contact printing or inkjet printing approaches.
61
 For the in situ polymerisation non-
volatile monomer, crosslinker and photoinitiator solutions are printed on top of each 
other. UV irradiation activates the initiator and after the polymerisation reaction, the 





The polymer microarrays generated by Voelcker et al. use plasma polymerisation to 
create star polyethylene glycol (PEG) or glucoside coatings which prevent cellular 
adherence.
62
 Similar to the Langer approach, the polymer features on the coated 
slides are in situ synthesised by step-wise contact printing of monomers, crosslinker 
and photoinitiator with solid pins followed by UV irradiation and water wash.
58,62
 By 
incorporating epoxy-groups in the cytophobic layer, the plasma polymerisation 





The Bradley group has developed three types of polymer microarray approaches 
using contact and non-contact printing techniques.  
The first developed polymer microarray consisted of microscope slides that were dip-
coated in agarose solution.
60,20,29
 Preformed polymer solutions (1 % (w/v) in                      
N-methyl-2-pyrrolidone (NMP)) of polyacrylates and polyurethanes are deposited on 
the slides in a fast and efficient manner by contact-printing using solid pins.
29,63
  
A second type of polymer microarray has been invented to maximise the amount of 
polymer features on one slide.
24
 For this purpose, a hydrofluoros mask was generated 
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on the microscope slide which defines the polymer position and size. To enable the 
anchoring of the acrylate monomers, an acrylate silane is coated on the empty 
features. Monomer, crosslinker and photo- or redox initator are printed on top of 
each other and form in situ polymers after irradiation and/or heating.  
For the generation of complex microarrays which take several hours, it was shown 
that a paraffin oil layer can be applied on top of the microscope slide. This prevents 
the evaporation of printed features for more than four hours and with it the uneven 
distribution of printed molecules within the spot.
25,64
 The polymer spots generated 
via this method are relatively large (600 µm) and extensive washing is required to 
remove the oil film.
25
 
The third approach towards generating polymer microarrays is presented in this 
thesis and deals with the fabrication of gradient polymer microarrays. In this case, 
gradient lines instead of single polymer spots are generated via inkjet printing whose 
polymer composition changes along the length of the line. Hydrofluoros masks 
define the length and width of the final gradient lines. In contrast to the previous 
polymer microarrays, the gradient array can be used for the investigations of cellular 
migration and is the first tool which combines a high-throughput approach with true 






Aim of the Thesis 
The aim of this thesis was to develop new types of polymer microarrays for cellular 
based applications. Diverse polymer microarrays have been fabricated which were 
used to identify polyacrylates which 
 control human embryonic stem cell fate and have the potential to be future 
synthetic cultivation substitutes in place of current biological substrates. 
 support adherence of suspension and adherent cell lines. 
 activate platelets more rapidly and efficiently than the natural agonist 
collagen in static and flow experiments. Subsequently the mechanism of this 
activation process was further investigated with protein binding studies. 
 sort megakaryocytic cell lineages according to their maturation status. 
 
Moreover, the first gradient polymer microarray was developed which also enabled 
the fabrication of protein gradients. These were used to develop a haptotaxis assay to 

















Chapter 2: High-Density Polymer Microarrays: 
Identifying Synthetic Substrates to Control Stem Cell 
Fate  
As described in Chapter 1, polymer microarrays are a high-throughput tool for the 
fast and effective screening of thousands of different substrates simultaneously. The 
number of deposited materials on an array (normally a microscope slide) depends on 
the feature sizes, the distances between them and the fabrication method used in their 
construction, be it via printing needles or ink-jet nozzles. 
 
2.1 Types of Polymer Microarrays 
Polymer microarrays are traditionally generated by contact-printing of preformed 
polymers or monomer solutions onto cytophobic materials such as agarose or poly(2-
hydroxyethyl methacrylate) using flat tipped needles. Due to the spreading of printed 
solutions when printed onto cytophobic substrates, the polymer spots generated are 
typically about 300-350 µm in size.
20,65 
Hence, the largest arrays that can be prepared 




The application of ink-jet printing for the fabrication of polymer microarrays enables 
a reduction in spot size to 200 µm, which is attributed to the use of a hydrofluorous 
mask which defines the spot size, their exact location and prevents unwanted 
spreading of the deposited solutions on the slides.
24 
The size of the deposited 
polymer spots depends on the nozzle of the printer (defining the drop size) and the 
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number of drops per printed feature. The largest arrays printed in this manner 
consists of 2436 polymer features and have been successfully applied for the 
identification of suitable binding materials for mouse embryonic stem cells.
 
The 
development of a larger polymer microarray was, however, desirable for the 
investigation of polymers with a large variability in their monomer composition in 
regard to stem cell binding and growth. 
 
2.2 Stem Cells  
Stem cells possess the unique ability to undergo cell division while maintaining an 
undifferentiated state (self-renewal) and having the capacity to differentiate into 
other cell types (potency).
66-68
 The potential of stem cells to differentiate into diverse 
cell types (plasticity), migrate to the site of damaged tissue (homing) and to unite 
with other types of tissue (engraftment) gives hope that damaged or diseased tissue 
can be replaced or reconstructed in the future.
69-72
  
Generally, it can be distinguished between embryonic, adult and induced pluripotent  
stem cells. While embryonic stem cells can differentiate into any mature cell of the 
three primary germ layers (pluripotency), adult stem cells can only undergo lineage 
restricted differentiation (multipotency) and are located in all types of tissue acting as 
a repair/replacement system for the body.
67,68,73-76 
Another type of pluripotent cells 
are engineered induced pluripotent stem cells (iPSCs) which are derived by 
transfection of specific genes that are associated with stem cellness into non-
pluripotent cells (adult somatic cells).
77-80
 Despite being similar to natural pluripotent 
stem cells in morphology, expression of proteins, potency and self-renewal, it is still 
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being investigated to what extent iPSCs simulate embryo-derived pluripotent stem 
cells.
79,80 
For all stem cells it is essential to control culture conditions in order to 
prevent unwanted/uncontrolled differentiation. Transcription factors such as Oct-4, 




2.3 Embryonic Stem Cells  
Embryonic stem cells (ESCs) are isolated from cells located in a region of an early 




Figure 2.1: Human embryonic stem cell generation. After in vitro fertilisation, the 
early stage embryo (morula) becomes a blastocyst with pluripotent inner mass cells. 
Cultivation of these cells on mouse fibroblast feeder cells generates embryonic stem 
cells that can be used in the laboratory.
90 
 
Cell line derivation is a complex process which is not completely understood - hence, 
the derivation of hESC lines is mostly carried out on human or mouse feeder cells 
and not on proteins or peptides of the extracellular matrix (ECM) (unlike the actual 
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cultivation). Feeder cells are thought to imitate better the conditions in the body and 
are hence beneficial for the creation of stem cell lines with true stem cell 
characteristics. Mouse feeder cells have several disadvantages over human 
fibroblasts as they increase the risk of transmission of infectious diseases from 
animal to humans (zoonosis). Moreover, it has been observed that a non-human sialic 
acid (Neu5Gc) from mouse feeder cells can be incorporated into hESCs.
91 
As 
specific antibodies against this sialic acid are present in the human body, transplanted 
hESCs would be killed by the body’s own immune system, leading to rejection of the 
transplanted cells.
91  
For the hESC derivation in vitro fertilised embryos that are classified as “not 
suitable” for embryo transfer - either because of poor morphology or because of the 
law-enforced cryo-storage limitation time (UK: 55 years since 2009 - present a good 
source for hESC lines.
92
 The embryos would be normally discarded and offer 
therefore a more ethical acceptable source for stem cell lines than fully intact 
embryos.
93,94
 The success rate for hESC line formation depends on the quality of the 
used embryo. The probability to generate hESC lines is about 15% for embryos that 
are suitable for a transplantation, while this probability shrinks to 1-3% for embryos 
with a poor morphology.
95-101  
Once the hESC lines are established, the cells are normally grown on human feeder 
cells or, alternatively, in fully synthetic, serum-free medium such as mTESR or 
StemPro on animal- or human-derived ECM protein substrates.
95,96
 While the risk of 
pathogen transmission in the feeder-free cultivation system is low and scaling-up can 
be easily achieved, the ECM proteins are expensive and the extraction and/or 
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production in large quantities for clinical therapies is difficult to realize. In addition, 
the self-renewal ability of some hESC lines is not supported.
92,93  
 
2.4 Current Substrates for Stem Cell Cultivation without Feeder Layer 
Cells 
The self-renewal and controlled differentiation of hESC on a complete synthetic 
substrate in fully-defined and serum-free medium is a necessary step to allow stem 
cell therapy to become a reality. However, as the identification of substitutes for 
complex ECM proteins has proven to be challenging, the most widely applied hESC 
substrate is Matrigel
TM
; an ECM analogue, which is extracted from Engelbreth-
Holm-Swarm mouse sarcoma cells.
102-105 
The main components of Matrigel
TM
 are 
basement membrane components such as collagen, laminin and entactin, but also a 
variety of growth factors such as basic fibroblast growth factor (bFGF) or epidermal 
growth factor (EGF).
103 
Batch-to-batch variability and the potential exposure of non-
human sialic acid (an immunogenic molecule) to stem cells prevent its use as a 
substrate for clinical-grade hESCs.
106  
The search for defined protein and peptide substitutes has shown that in long term 
studies (> 10 passages) immobilised human plasma vitronectin and human 
recombinant laminin-511 can be used as a stem cell substrate.
106-108
 In both cases 
these proteins are present in the ECM and are crucial for cell-adhesion and cell-
migration.
106,108,109 
In addition, a variety of synthetic heparin-binding peptides (singly 
or in combination) and a short peptide version of vitronectin also facilitated the long-





In contrast to proteins and peptides, synthetic polymer coatings that can control stem 
cell fate would offer a cheap, scaleable alternative that would survive long-term 
storage conditions and allow facile sterilisation. Moreover, polymers could be easily 
modified to control differentiation of stem cells into defined lineages by attaching 
certain peptides or small molecules.
87,112 
So far there have been several synthetic polymer matrices identified which support 
hESC propagation.
113-115
 However, only one polymer - poly(2-methacryloyloxy)ethyl 
dimethyl-(3-sulfopropyl)ammonium hydroxide (PMEDSAH) - has been shown to 
support hESC growth of the H9 cell line during long-term studies in undefined and 
defined, serum-free medium.
112
 While the cell line H9 could be passaged for more 
than 10 passages on the polymer substrate maintaining pluripotency, the hESC line 
BG01 could only be cultivated for 3 passages under the same conditions. It was also 
shown that the defined medium StemPro had to be used for successful cultivation 
(differentiation was observed with mTESR). While StemPro is a defined medium, 
the concrete composition of the medium is not published, making it difficult to 
identify the protein binding characteristics for the substrate.
112
 
Further investigations are needed to identify synthetic, polymeric hESC substrates 
that support the propagation of a variety of hESC lines under defined conditions and 
open the door for the production of clinical-grade stem cells on a large scale. As 
some surfaces support maintenance of cells but not their propagation or control of 
differentiation and are only selective for certain hESC lines, it is essential to screen a 
large variety of polymer substrates to identify optimal matrices.
87
 Polymer-
microarrays are a promising tool for this search as multiple polymers can be screened 
in a time-effective manner under identical conditions.  
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2.5 Fabrication of High-Density Polymer Microarrays        
Polymer microarrays with more than 7000 features were generated in a two-step 
fabrication process (Figure 2.2a,b). In the first step, an aqueous sucrose solution was 
printed to generate a mask. The uncoated areas of the slide were treated with a 
hydrophobic fluoro-silane, which defined the subsequent spot size and prevented or 
reduced unwanted cellular attachment. The spot sizes and with it the general array 
size could be easily varied by changing the number of sugar drops per feature (Table 
2.1). 
 
Table 2.1: Variation of spot size and subsequent array size. The features were ink-jet 




Distance between Spots 
(X and Y direction)  
[µm] 
Total number of spots 
(X direction x Y direction) 
15 800 29 x 62 
12 700 33 x 70 
6 500 47 x 99 
3 450 53 x 110 
2 400 59 x 124 












Figure 2.2: The fabrication of a high-density polymer microarray. a) The fabrication 
process. In the first step a fluoro-mask is prepared to define spot sizes and to 
prevent/reduce background cellular attachment. In the second step the monomers, 
crosslinker and photoinitiator are printed on the acrylate functionalised areas 
forming corsslinked polymers after UV irradiation.
24
 b) Image of the final high-
density array with 7316 polymer features, 50 columns (with 124 spots in the y 
direction); Insert shows magnification of ten columns. c) Acrylate and acrylamide 













In the second step, the sucrose spots were removed, revealing glass features that were 
subsequently coated with an acrylate silane. For the fabrication of a high-density 
array, two monomers (out of 26 different acrylates and acrylamides) were printed in 
different ratios (20% steps) along with a crosslinker and a photoinitiator, allowing 
the efficient generation of a large number of compositions with a range of 
characteristics (Figure 2.2c).  
This method allowed the fabrication of a polymer microarray consisting of 7316 
features (with diameters of 200 ± 20 µm) and displayed a smooth, uniform 
morphology (scanning electron microscopy, Figure 2.3a). The uniformity of the 
monomers mixed within the spots was investigated using energy dispersive X-ray 
spectroscopy (EDX) for polymers containing the monomers 2-hydroxyethyl 





Figure 2.3: SEM and EDX-profile of polymer spots containing the monomers                     
2-hydroxyethyl methacrylate and ethylene glycol methacrylate phosphate. a) Colour 
intensity profile for a whole polymer feature. Bars = 100µm. b) Carbon, oxygen, 
phosphorus signal intensities for central and side regions of a representative 
polymer spot (n=3): black, red - centre of spot, blue, green - edge of spot.  
 
 
This analysis demonstrated uniform carbon, oxygen and phosphorus intensity 
profiles across the features, showing that the element content was equally distributed 





The variety of acrylates/acrylamides and group diversity make the array an ideal 
platform for the identification of appropriate matrix polymers for the stable, robust 
phenotypic control of in vitro stem cell cultivation. The hESC line RH1 was 
incubated for 4 d on the high-density arrays, and the cells were subsequently fixed, 
stained with 4',6-diamidino-2-phenylindole (DAPI, blue nucleus stain) and a FITC-
labelled antibody to the Octamer binding transcription factor 4 (Oct-4, stem cell 
marker) (Figure 2.4).
95‡ 
All hESCs that had been captured by the polymers showed 
Oct-4 expression, demonstrating pluripotency of the cells. The number of cells bound 











                                                 
‡
 All hESC work was jointly carried out with Heidi K. Mjoseng in the Centre for Regenerative 




   
 
Figure 2.4: Analysis of polymer microarrays after hESC incubation. a) Typical 
images of features from a strong-binding polymer on the high-density array after 4 d 
of incubation. Cells are stained with DAPI (blue) and an antibody against Oct-4 
(green). Bars = 100 µm. b) Polymer array analysis after 4 d incubation with hESCs. 








The top cell binding polymer in the microarray studies consisted of the hydrophobic 
4-tert-butylcyclohexyl acrylate (monomer 9) and n-butyl methacrylate (monomer 10) 
in equal ratios. This is in contrast to many previous studies where charged surfaces 
were successfully used for hESC cultivation.
116,117
 
The most prominent monomers appearing in seven of the 26 identified hESC binding 
polymers were 2-carboxyethyl acrylate (monomer 2) and 2-(methylthio)ethyl 
methacrylate (monomer 8). Most monomer combinations with these monomers 
bound cells, but only at one specific ratio. This suggests that the specific ratios 
display very different characteristics and that only minor ratio changes are tolerated 
by the hESCs. This finding is in accord with previous studies where hESC binding 
strongly depended on the acid content of the surface and the medium.
75
 To gain an 
understanding of the interaction between the identified polymer substrates and hESC 
growth, surface wettability and surface roughness of the polymers were determined. 
While the surface wettability (measured as water contact angle) has been correlated 
to protein adsorption and cellular binding, it has been suggested that surface 
roughness has an influence on cellular adherence and proliferation.
116,118-120
 For the 
characterisation of the surface properties, the five best binding polymers of the 
microarray (Figure 2.4b) were coated onto coverslips and analysed.
74,121
 The water 
contact angles for the identified polymers 1, 2, 4 and 5 varied between 46 – 59 ° 
(Table 2.2), values that are in a range normally supporting cellular attachment.
116
 
Polyacrylate 3 had a water contact angle of 37 ° which was expected since the 2-
carboxyethyl acrylate (monomer 17) contains carboxylic acid groups and was in 
fivefold excess to the second monomer 2-(diethylamino)-ethyl acrylate (monomer 3). 





 While the polymers 1 and 3 gave values of about 0.14 - 0.15 µm, 
the surface roughness of the polymers 2, 4 and 5 varied between 0.01 – 0.04 µm 
(Table 2.1, Figure 2.5).  
 
 
Figure 2.5: Representative roughness profiles for the polymers supporting hESC 
proliferation recorded by AFM: a) polymer 1 and b) polymer 4. 
 
However, the roughness did not have any influence on the cell proliferation as the 
overall cellular expansion time on the hit polyacrylates were comparable to 
Matrigel
TM







                                                 
¥
 The AFM images and corresponding measurements were kindly provided by Michail Kalloudis 




Table 2.2: Characterisation of the five best polymers identified from the high-
density array that supported hESC proliferation and self-renewal. Presented data for 
water contact angle and cell doubling time (standard deviation (n=5)). 












3:3 M9/M10 55.7 ± 2.6 0.138 ± 0.015 48.5 ± 7.3 
2 3:3 M2/M15 56.0 ± 3.3 0.038 ± 0.005 53.1 ± 7.5 
3 1:5 M3/M17 37.3 ± 1.9 0.148 ± 0.030 51.6 ± 4.8 
4 3:3 M4/M12 45.7 ± 1.0 0.017 ± 0.010 43.8 ± 1.9 
5 3:3 M9/M24 58.7 ± 3.2 0.014 ± 0.005 43.2 ± 12.2 
* Matrigel
TM
 gave a cell doubling time of 41.3 ± 7.4 h. 
 
To determine the ability of the polymers to maintain the characteristics of hESCs 
over several passages, cells were seeded on the five best polyacrylates and the 
positive control Matrigel
TM
 and incubated for 35 days (being passaged approximately 
every 7 days). As expected, the cells adhered easily to the different polymers, 
showing a similar morphology to the Matrigel
TM
 control.  
After five passages, cells were fixed and stained with fluorescent labelled Nanog and 
Oct-4 antibodies as these transcription factors are critically involved in the self-
renewal of hESCs.
122,123
 As shown in Figure 2.6a, the fluorescence intensity for both 
markers on the positive control Matrigel
TM
 as well as the polyacrylates 1, 2, 4 and 5 
were comparable, showing that the polymers maintained stem cell pluripotency. 
Cells on polymer 3 were positive for Nanog staining but failed to show strong 
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expression of Oct-4, showing progressed differentiation. hESCs were harvested and 
analysed by flow cytometry for quantitative analysis of markers of hESC 
differentiation: SSEA-1 and SSEA-4 (Figure 2.6b).
123,124 
While SSEA-4 is expressed 
by hESCs it becomes down regulated upon loss of pluripotency, while SSEA-1 is up-
regulated in the case of differentiation. About 90% of the hESCs maintained their 
pluripotency after 35 days of culture (SSEA-4 positive, SSEA-1 negative) on the 
control Matrigel
TM
 and polymer 1. The identified polyacrylates 2, 4 and 5 had a 
slightly lower population (~80%) of undifferentiated cells that were SSEA-4 
positive. Polymer 3 had a high differentiation rate, only maintaining 29% of the cells 
in their pluripotent state. This might be due to the lower water contact angle which 
was shown to be less ideal for stem cell cultivation.
116
 While short term cultivation 
on this polymer might be possible (as shown on the high-density array results), long-















Figure 2.6a: Representative images of immunostained hESCs cultivated on Matrigel
TM
 and polyacrylates 1-5 for 5 passages:                      










Figure 2.6b: Representative flow cytometry analysis of hESCs cultivated on Matrigel
TM
 and polyacrylates 1-5 for 5 passages. hESC 
were stained for stem cell marker SSEA-1 and SSEA-4. Red population: Matrigel TM, blue population: cells on polymers. 
 







In summary, it has been shown that the high-density polymer approach takes 
polymer screening to a new level by allowing up to 7000 different polymeric 
materials to be simultaneously evaluated. The high-density array is suitable for 
cellular adherence studies and allows a more rapid and more uniform analysis of a 
larger number of polymers than previous high-throughput techniques and polymer 
microarrays. Up-scaling of the identified hit polymers confirmed the succesful 
application of the high-density array approach. Immunocytohistology chemistry and 
flow cytometry showed in a qualitative and a quantitative way the successful stem-
cell maintenance on synthetic substrates. It has been shown in long-term studies that 
the best binding polyacrylates 1 (poly(4-tert-butylcyclohexyl acrylate-co-n-butyl 
methacrylate) (50:50)), 2 (poly(2-carboxyethyl acrylate-co-ethylene glycol 
methacrylate phosphate) (50:50)), 4 (poly(2-(diethylamino)ethyl methacrylate-co-
ethylene glycol dicyclopentenyl ether acrylate) (50:50)) and 5 (poly(4-tert-
butylcyclohexyl acrylate-co-N,N-dimethylacrylamide) (50:50)) allowed for fully 
xeno-free and feeder-free hESC cultivation which is desirable for clinical 









Chapter 3: Fabrication of Arrays of Polymer Gradients 
using Inkjet Printing 
 
Parts of the presented work have been previously published as: 
A. Hansen, R. Zhang, M. Bradley; Fabrication of arrays of polymer gradients using 
inkjet printing. Macromol. Rapid Commun. doi:10.1002/marc.201200193. 
 
The large variety of readily-available monomers and their possible combinations can 
give rise to a wide variety of polymeric materials with diverse physical and chemical 
characteristics and numerous applications.
127-129
 By applying combinatorial or high-
throughput chemistry techniques, polymeric materials and optimised formulations 





combinatorial approach using material gradients was applied in the 
discovery of polymer combinations with optimised dewetting and cellular interaction 
properties.
133-135
 In contrast, non-combinatorial polymer microarray approaches offer 
discrete materials and not a combinatorial continuum (gradient) allowing thousands 
of defined, individual polymers to be investigated for the exploration of the link 
between polymer composition and cellular/protein adherence.
24,136-138 
The generation 
of polymer microarrays with multiple polymer gradients, combining both high-





3.1 Current Gradient Fabrications via Printing Techniques  
Two types of gradients can be generated: concentration and composition gradients 
(Figure 3.1). Concentration gradients are easy to fabricate by changing the total 
quantity of deposited material along the gradient length. The composition of the 
material remains constant, subsequently, the properties of the deposited material do 
not change. In contrast, in composition gradients the quantity of deposited material 
remains constant but the mixture of which the material is composed of changes along 
the gradient length. This gives materials with distinct properties in different 
segments.   
 
 
Figure 3.1: Types of Gradients. The concentration gradient is characterised by a 
“quantity change” of deposited material, the composition gradient leads to a 
controlled variation in the composition of the final compound. Here, the quantity of 





A number of methods have been developed to generate polymer gradients including 





microfluidic devices have been used to control the 
infusion rates of two monomer solutions to give polymer gradients while 
biomolecules can be attached upon such gradients by controlled physical adsorption 
or covalent immobilisation.
142,147-154
 Microcontact and ink-jet printing techniques 
have been used to generate concentration gradients of proteins and small molecules 
or self-assembled monolayers (SAMs).
155-157 
While biomolecule gradients have been 
used for the control of cellular alignment, stem cell differentiation or the 
determination of minimal inhibition concentrations of antibiotics, the 
functionalisation of surfaces with SAMs in a gradient manner have been applied for 
controlled droplet movement or the adsorption of proteins and cellular adhesion.
133-
161 
The generation of concentration gradients via printing techniques can be easily 
achieved as it requires the direct deposition of materials. In the case of microcontact 
printing, the type of gradient (radial or lateral) is controlled by the type of stamp 
used, whereas the steepness of the gradient can be varied by changing the contact 






Figure 3.2: The generation of different concentration gradients using microcontact 
printing of elastomeric stamps or ink-jet printing. While for the contact printing 
approach different stamps are used to fabricate radial, one-directional or 
symmetrical lateral gradients, the ink jet printing approach makes use of the flexible 





The fabrication of concentration gradients via ink-jet printing is carried out by 
printing features in close or far-proximity from each other (Figure 3.2). As the nozzle 
can be flexibly moved, the gradient fabrication is only limited by the drop sizes of 
the ink (resolution can be up to 1 µm).
163
 The concentration gradient steepness and 
form can be easily modified by changing the printing pattern (Figure 3.2).
158,162  
In contrast, the generation of composition gradients via printing techniques is 
challenging as it requires not only a pure deposition but also a controlled mixing 
process that varies the content of the deposited material. As the generation of 
composition gradients on a microarray platform was required for the simultaneous 
evaluation of different polymer compositions for biological studies, a new technique 
had to be developed. 
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3.2 Cellular Migration  
In organisms, cells have to migrate in specific directions to certain locations in order 
to ensure proper organism development, growth and repair at site of injuries. 
Problems in cellular migration during development can lead to congenital 
abnormalities, and in adult life can cause vascular disease, tumour formation and 
metastasis.
164-174 
For organised cellular movements to occur, external signalling 
molecules are important that direct specific cells to the different locations.
 
While 
chemoattractants lead to a movement of the cells towards the higher concentration of 
the molecule, chemorepellents have the opposite effect. The term cellular migration 
can be divided into different forms, depending on how the cells are receiving the 
signals and how the cells move/ respond. The most studied type of cellular migration 
is chemotaxis, which describes a directed cellular movement along a soluble signal 
gradient. Diverse assays have been developed to measure chemotaxis in a qualitative 
and quantitative manner. The most applied method is the Boyden chamber assay, 
which was originally introduced for the analysis of leucocyte chemotaxis.
172
 In this 
assay, two compartments of a chamber are separated by a microporous membrane 
(Figure 3.3). Cells are placed in the upper part and migrate through the membrane 
due to the chemotactic agents in the lower compartment, which diffuses into the 
upper part and creates a chemotactic gradient. After an appropriate incubation time, 
the cell amount in the lower part of the separating membrane can be analysed. 
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Figure 3.3: Principle of Boyden Chamber. At the beginning of the experiment, the 
cells are in the upper chamber. The chemotactic compound in the lower 
compartment induces chemotaxis through the permeable membrane into the lower 






Similar techniques include devices with chambers arranged side-by side, connected 
via a narrow channel which allows the cellular migration from one chamber into the 
other (Dunn and Zigmond Chamber) or flow-based microdevices which create stable 
concentration gradients and investigate the cellular movements by live 
microscopy.
173-176
 Other types of cellular migrations in the liquid phase are 
necrotaxis (necrotic or apoptotic cells release the chemoattractant molecules) and 
chemokinesis (random cellular movement without directional component) which can 
be investigated with the same types of apparatuses as described for chemotaxis.
164-
169
As these assays are simple and commercially available, the investigation of 
cellular movement in liquid phases is well understood.  
A different form of cellular movement is haptotaxis which describes the directed 
cellular movement on a surface with bound or expressed gradients of signal 
molecules. The most common hapotactic surface is the extracellular matrix (ECM) 
which can control the cellular movement of certain cell types by expressing or 
binding specific ligands. The formation of new blood vessels (angiogenesis) or the 





 For the investigation of haptotaxis, Boyden chambers are 
commercially available which have permeable membranes that are coated on one 
side with widely studied ECM proteins such as fibrinogen or collagen.
177-179
 
However, the generation of a tailored high-throughput chemoattractant/repellant 
microarray is of interest for the investigation of biological events that depend on 
proteins bound to the ECM, which are not constantly present and/or are not widely 
studied, such as semaphorins.  
 
3.3 Semaphorins as Chemoattractants/Chemorepellents in Cellular 
Migration 
Semaphorins are a family of signaling proteins which are important in the axon 
guidance of neuron cells, immune response, vascular growth and tumor 
progression.
180
 The protein family consists of secreted and transmembrane proteins 
that are present in invertebrates, vertebrates and viruses. The molecular size of the 
semaphorins varies between 400 and 1000 amino acids.
181,182
 All semaphorins are 
characterised by a highly conserved domain at the N-terminus (sema-domain) which 
is about 500 amino acids long and contains 14 to 16 conserved cysteine residues and 
a N-glycosylation site.
183-185
 Semaphorin 3F (Sema3F) and semaphorin 3A (Sema3A) 
are chemoattractants or repellents (respectively) for oligodendrocytes in the central 
nervous system (CNS).
186
 This type of cell is responsible for the formation of the 
insulating myelin sheaths on axonal segments that are essential for fast and effective 




Figure 3.4: The interaction between neuron cells and oligodendrocytes in the central 
nervous system. Depending on the area of the CNS and the species, the amount and 





In case of demyelination, e.g. by the autoimmune disease multiple sclerosis, the 
axons can no longer effectively conduct nerve signals, which leads to physical and 
cognitive disabilities.
186-188
 So far, there is no cure for such demyelinating diseases 
but it is hoped that further investigations of the migration of oligodendrocytes and 
their precursor cells (OGPCs) by Sema3A and Sema3F will provide a better 
understanding of the biochemical processes.  
While Sema3A inhibits migration of oligodendrocytes and their precursor cells 
during development, Sema3F is a chemoattractant for these cells. After pathology, 
there is a recapitulation of these pathways, and Sema3A production by cells in 
demyelinated lesions inhibits OGPC migration into lesions and their maturation into 
myelinating oligodendrocytes.
189-191
 The comprehension of the concrete interplay of 
both semaphorins is the key for understanding how myelin repair in multiple 
sclerosis works and might lead to a therapy to improve remyelination in the disease. 
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To investigate the effect of the semaphorins in more detail, a haptotaxis assay based 
on a polymer gradient microarray with Sema3A and Sema3F attached was explored. 
The ideal polymer would support large numbers of OGPCs while not exerting a 
migration effect on the cells.  
 
3.4 Generation of Microarrays with Polymer Gradient Lines 
(Composition Gradients) 
To generate multiple gradient lines on a single microscope glass, ink-jet printing was 
chosen as the fabrication method of choice as it offers rapid and precise deposition of 
material in a very flexible manner. To obtain lines with a gradient of monomer 
compositions, a similar technique to that used for the spotted microarrays was 
applied (see Chapter 2, Figure 3.5) where a “masked” fluorous coating was used to 
determine the specific shape of the deposited polymers as well as reducing or 
limiting cellular attachment. The first step in the process consisted of masking the 
glass slide by printing lines (5 mm x 0.5 mm) of 20% aqueous sucrose (w/v) (Table 






Figure 3.5: The fabrication of polymer gradient arrays. a) Sugar mask printing (20 
% w/v) defines the polymer gradient length and width. b) Sugar spots in close 
proximity (200 µm) merge to form lines. c) The microscope slide is made 
hydrofluorous by treating with (tridecafluoro-1,1,2,2-tetrahydrooctyl) 
dimethylchlorosilane. After removal of the mask (water wash), the lines are derivated 
with 3-(trimethyoxysilyl)propyl methacrylate. d) The acrylate monomers are printed 
in a gradient manner on the functionalised lines. e) After compression, irradiation 
and incubation the polymer gradient array is generated. 
 
 
The glass slide was coated with (tridecafluoro-1,1,2,2-tetrahydrooctyl) 
dimethylchlorosilane and the sucrose masking removed. The exposed glass surfaces 
were functionalised with 3-(trimethyoxysilyl)propyl methacrylate, enabling the 
anchoring of the in situ synthesised polymers. Polymer gradients were generated by 
printing monomers together with a crosslinker and a photoinitiator across the acrylate 
functionalised surface. After compression of the printed features with a second 
hydrofluorous slide, the slides were UV irradiated for 20 min and incubated at 50 °C 
for 16 h to ensure complete polymerisation. To identify the optimal compression 
technique and printing scheme for the generation of linear gradients, different 
combinations of initiator and monomer ratios of 2-hydroxyethyl methacrylate and 
ethylene glycol methacrylate phosphate were printed and evaluated (see Table 3.1). 
The phosphate monomer allowed phosphorus (2p) analysis via X-Ray photoelectron 
spectroscopy (XPS). As shown in Figure 3.6, the compression and printing scheme is 






Table 3.1: Printing Schemes 
Line Masking Procedure 
Polymer Gradient Generation 
Print Compounds 
Deposited Drops on Position along Gradient Length 
[µm] 





25 spots (each 3 drops 
of 20 % (w/v) sucrose) 
printed 0.2 mm apart in 
3 lines (each line               
0.2 mm apart) 
1 
Monomer A 36       30        0          0          0           0 
0          0         0          0         30         36 
18       15        0          0         15         18 
9          9         0          0          9           9  








Monomer A 16        8          4          2          1           0 
0          1          2          4          8         16 
5          5          5          5          5          5 
3          3          3          3          3          3 









Monomer A 19       15        12        8          3          0 
0          3          8        12        15        19 
5          5          5         5          5          5 
2          2          2         2          2          2 












Figure 3.6: XPS analysis of polymer lines generated with 2-hydroxyethyl 
methacrylate and ethylene glycol methacrylate phosphate. a) Printing scheme “1” 
with fixation by paper clamps; b) printing scheme “1”, c) printing scheme “2” using 
redox-and photoinitiator, d) printing scheme “3” using only photoinitiator. 
 
 
The first printing schemes consisted of monomers being deposited at either end of 
the lines separated by a space of 2500 um apart within which initiator drops were 
placed. It was expected that compression of the printed features would result in 
blending of the monomer solutions in the centre, giving a linear polymer gradient. 
For compression, a second fluorous slide was placed on top of the printed array. To 
ensure further fixation, paper clamps were used after the first printing attempt of 
printing pattern 1 (Figure 3.6a). However, this fixation resulted in a high pressure 
applied and lead to uncontrolled blending of the monomers and, subsequently, no 
gradient formation. Compression without further fixation gave phosphorus-profiles 





(Figure 3.6b). Printing schemes with a continuous increase of the deposited 
monomers along the lines gave linear gradient profiles (Figure 3.6c and d). Gradients 
generated with a smaller amount of initiator gave a slightly more linear profile which 
might be due to less diffusion effects (Figure 3.6d). To ensure that the gradients 
generated via printing scheme “3” were independent of the location on the 
microscope slide, gradient lines on the centre and on edges of the microscope slide 
were generated and analysed via XPS (n=7, Figure 3.7a). Visualisation of the 
gradient was also accomplished by adding 5(6)-carboxyfluorescein to one of the 
monomer solutions prior to printing and polymerisation (Figure 3.7b) allowing the 
composition of the polymer to be known simply by determining its location along the 
gradient (Figure 3.7, Appendix Figure1). 
 
 
Figure 3.7: a) The average XPS data measurements of the P (2p) signal intensity 
along the gradient array consisting of ethylene glycol methacrylate phosphate and 2-
hydroxyethyl methacrylate (B6 and B22) (n=7). b) Visualisation of the gradient 
prepared with (2-diethylamino)ethyl acrylate and 2-hydroxyethyl methacrylate mixed 






An array with 84 polymer gradients each consisting of two monomer combinations 
with (2-diethylamino)ethyl acrylate (monomer A) and a variety of second acrylate 





















Figure 3.8: a) Polymer gradient array: Grey lines represent triplicates of two-
component gradients of  monomer A and monomers B1-23. The black lines represent 
XPS-control gradients consisting of monomers B22 and B6 (ethylene glycol 
methacrylate phosphate and 2-hydroxy-ethyl methacrylate). b) Image of polymer 
gradient array with a mosaic of a polymer gradient line (5 mm x 0.5 mm).                         










3.5 Cellular Binding Studies on Polymer Gradient Arrays 
The adhesion and growth of the suspension cell line K562 on the polymer gradients 
was explored. After 3 d incubation, the K562 cells were fixed and counted along the 
gradients (Figure 3.9a) giving a clear understanding of how the different types of 
monomer affect cellular adhesion and growth. An overview of the cellular adherence 
on all different gradient line compositions is given in Appendix Figure 3.1. In 
accordance with previous studies, monomers A and B5 ((2-dimethylamino)ethyl 
acrylate) demonstrated high cellular adhesion (up to 10000 cells/mm
2
, Figure 3.9b) 
in all ratios.
134 
According to the previous studies, the best binding co-polymers 
consisted of a hydroxyl monomer and an amine-monomer in a ratio of 70:30 (4000 
cells/mm
2
, Figure 3.9c). The gradient arrays showed that the best binding material 
for K562 was a composition of monomer A and monomer B12 (2-carboxyethyl 
acrylate oligomer) in a ratio of 40:60, with over 15000 cells/mm
2
 bound (Figure 
3.9d), while the related monomer B1 (2-carboxyethyl acrylate) did not demonstrate 
any increasing cell binding effect (Figure 3.9e).
134 
Adherence studies carried out with 
the adherent cell line (HeLa) showed that a high content of alcohol containing 
monomers e.g. (2-hydroxyethyl methacrylate (> 90%) and 4-hydroxybutyl acrylate 
(> 50%) and certain amides (N-isopropylacrylamide (> 60%) and 2-
diethylacrylamide (> 75%) were found to improve HeLa cell binding (Figure 
3.10).
24§ 
These results demonstrate the successful application of the polymer gradient 
arrays and give detailed information about how far the variation in monomer content 
is tolerated by cells. 
                                                 
§




Figure 3.9: a) Mosaic of a typical polymer gradient with K562 cells attached (high-
content imaging of four segments 5 mm x 0.5 mm, scale bar = 0.5 mm). b-e) 
Representative gradient profiles of the number of bound cells as a function of 
monomer composition. Monomer A is (2-diethylamino)ethyl acrylate, monomer B is 
(2-dimethylamino)ethyl acrylate (b); 2-hydroxyethyl methacrylate (c); 2-








Figure 3.10: Cell binding profiles of HeLa cells across polymer gradients. Monomer 
A is (2-diethylamino)ethyl acrylate, monomer B is a) 2-hydroxy ethyl methacrylate; 
b) 4-hydroxybutyl acrylate; c) N,N-diethyl acrylamide; d) N-isopropylacrylamide 


















3.6 Generation of Molecule Gradients (Concentration Gradients) 
 
The polymer gradient arrays allow the further modification and generation of small 
molecule, peptide or protein concentration gradients. By applying common activation 
strategies, polymer gradients with 2-carboxyethyl methacrylate or the active ester             




Figure 3.11: Coupling-scheme for attaching proteins to an acid functionalised 
polymer substrate. This strategy can be used for any molecule containing an amine-
group. 
 
To generate a gradient of a readily visualised dye, polymer gradients composed of        
N-acryloxysuccinimide and 2-hydroxyethyl methacrylate were fabricated and 
derivatisation with 6-aminofluorescein to give fluorescent gradient lines (Figure 
3.12). 
 
Figure 3.12: Visualisation of the polymer gradients prepared from                                  
N-acryloxysuccinimide and 2-hydroxyethyl methacrylate shown before and after the 




3.7 Generation of a Semaphorin Haptotaxis Array for OGPCs** 
 
Polymer gradients with 2-carboxyethyl methacrylate were the basis for the protein 
gradients as they enable the immobilisation of proteins in a gradient manner by 
applying common peptide coupling strategies. To ensure that the migration 
behaviour of OGPCs is independent from the polymer and only controlled by the 
protein, preliminary studies with polymer gradient lines containing 2-carboxyethyl 
methacrylate as a monomer were carried out. It was determined that gradients lines 
composed of tert-butyl acrylate or tert-butylcyclohexyl acrylate with 2-carboxyethyl 
methacrylate were the best substrate for cell binding showing constant numbers of 
bound cells along the whole gradient length. For the generation of a protein gradient 
arrays with Sema3F, the polymer gradients were generated as described before 
(Chapter 3.4.) and the acid groups were activated by incubating the arrays with a 
mixture of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, 0.1 M) and                          
N-hydroxysuccinimide (5mM) in dry dimethylformamide (DMF) for 2 h. This was 
followed by the coupling of Sema3F (100 µg/mL) in PBS for 1.5 h (Figure 3.11). 
The successful coupling was verified by fluorescence imaging before and after the 
coupling and the subsequently binding to a specific, Cy5 tagged Sema3F antibody 




                                                 
**
 The cellular binding studies of OGPCs in this chapter were carried out by Jonathan Murnane and 





Figure 3.13: Sema3F gradient microarray a) Layout scheme, 3F = high 
concentration of Sema3F on that particular end of the gradient, Gradient monomers: 
2-carboxyethyl methacrylate with BA=tert-butyl acrylate or BCA=tert-
butylcyclohexyl acrylate. Lines without Sema3F served as negative controls.                     
b) Protein microarray lines before and after incubation with a Cy5-labelled Sema3F 
antibody. 
 
The fluorescence distribution of each gradient line was calculated by measuring the 
fluorescence intensity at 15 adjacent areas along each line. As it can be seen in 
Figure 3.14, the resulting graphs give a linear relation between fluorescence intensity 
and calculated Sema3F content bound to the polymer gradient. As negative controls 
served polymer gradients without Sema3F (Figure 3.14c). All fluorescent studies 
were independent of the monomer composition of the polymer gradients. 
 
a b 
BA       BA       BCA     BCA       





Figure 3.14: Fluorescence Intensity profiles for the gradient lines after semaphorin 
3F antibody staining. a). Gradient lines with increasing Sema3F content (n=10), b) 
gradient lines with decreasing Sema3F content (n=7), c) negative control - gradient 
without Sema3F coupled to the polymers (n=3). 
 
After establishing the succesful coupling of Sema3F onto the polymer gradients, rat 
OGPCs were incubated onto the protein gradient arrays for 18 h. After washing and 
fixing, the cells were counted at each end of the gradient lines. On the control 
gradients and at the end of the gradient line without Sema3F approximately 400 
cells/ mm
2 
adhered. In contrast, those gradient line ends with the protein attached to 
it, gave binding of about 600 cells/mm
2







Figure 3.15: Cell binding of OGPCs on the Sema3F gradients. Gradient ends with a 
high concentration of Sema3F bound significantly more cells than those ends with a 
low protein concentration. P<0.01 by one-way ANOVA. 
 
Since the difference between the cellular binding on high and low protein 
concentrations is statistically significant (P<0.01 by one-way ANOVA), the result 
underlines the chemoattractant effect of Sema3F on OGPCs in in vitro studies. To 
monitor the migration of the cells on the protein gradients, images of the end of the 
gradients were taken every 10 min after the cells were plated. As shown in Figure 
3.16, cells could be seen migrating towards the higher protein concentrations. 
58 
 
Figure 3.16: Time-lapse recording of OGPCs at one end of a Sema3F gradient. 
Highlighted in a yellow circle is a cell migrating towards the higher protein 
concentration. Scale bars = 100 µm.  
 
 
To date, studies testing the chemotactic effect of Sema3F on oligodendrocytes or 
axon growth cones have been carried out in solution only. Thus, this is the first 
haptotaxis investigation for this system. In the brain, the protein Sema3F is bound to 
the ECM, in the presented system, a polyacrylate mimics the ECM to which the 










This study served to illustrate the ability of polymer gradient arrays to determine the 
optimal combination of two acrylate monomers in cellular adherence studies. 
Cellular binding results corroborate previous polymer microarray investigations with 
the gradient array identifying the best binding combinations but, due to the 
continuum approach, explored in detail the precise composition of monomers which 
leads to the highest cell binding. Furthermore, it has been shown that the arrays can 
be readily modified to allow the fabrication of gradients with controlled 
characteristics. Thus, coupling with proteins could be achieved and used for an 
investigation of processes such as controlled cellular migration. For the generation of 
a haptotaxis assay, two polymers from a carboxy-gradient line array were identified 
which adhered OGPCs but did not exert migration preferences themselves. By 
coupling the chemoattractant Sema3F onto the polymers, protein concentration 
gradients were generated that successfully lead to the migration of OGPCs. This 
presents the first haptotaxis assay for this protein system and might be useful for 















Chapter 4: Polymers for Platelet Activation and 
Sorting of Megakaryocytic Cell Lines 
 
Parts of the presented work have been previously published as: 
A. Hansen, L. McMillan, A. Morrison, J. Petrik, M. Bradley; Polymers for the rapid 
and effective activation and aggregation of platelets. Biomaterials 2011, 32, 7034-
7041. 
 
Platelets play a central role in mediating haemostasis and thrombosis by reacting 
rapidly to vascular injuries with platelet adherence and activation leading, finally, to 
the formation of a “haemostatic plug”.
192
 
While most biocompatibility studies on platelets have focussed on materials which 
avoid platelet activation for potential use in transplantation, fast and effective platelet 
aggregation is desired and even essential for haemostasis of (severe) injuries. For 
centuries, cauterisation has been the prime method for haemostasis.
193
 The first 
material specially tailored for bleeding control was oxycellulose, developed in 1942 
and is still in use today.
194
 Since the first haemostatic agent, new materials such as 
fibrin sealants or surgical stapling have been developed.
195,196
 While naturally 
derived products based on fibrin, chitosan, collagen or plant extracts offer effective 
haemostasis with mostly degradable end-products, the extraction and purification 
steps are time- and cost-intensive.
197-199 
An alternative to these products could be a 
synthetic polymer, which would offer advantages such as tuneable structure and 
shape, ease of functionalisation, synthesis and purification, prolonged long-life times 
61 
 
and consistency of generation while leading to rapid, controllable and efficient 
platelet activation.   
 
4.1 Platelets - a Special Type of Cell 





 For up to ten days, platelets circulate in the blood system until they are 
destroyed and replaced by new “cells”. Platelets are anucleated and vary in size               
(2-4 µm) and density. These characteristics are independent of platelet age and can 
be explained by a closer look at their formation process.
201 
 
4.2 Platelet Formation 
The mechanism by which platelets are produced has been studied since 1906 when 
Wright discovered that megakaryocytes are the giant precursor cells of the anuclear 
platelets.
202
 As platelet formation and release cannot be investigated in detail in vivo, 
cultivated megakaryocytes from bone marrow and permanent cell lines of 
megakaryocytic lineage such as MEG-01 have been used to study the exact process 




Figure 4.1: The maturation process of megakaryocytes. a) Premature cell; b) 
polyploid cell producing platelet specifics compounds; c) mature megakaryocyte 
with proplatelets; d) release of platelets.
203 
a                            b                                     c                                               d   
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While megakaryocytes mature, they undergo endomitosis – a process of repeated 
cycles of DNA replication without cell division. As a result the cells become 
polyploid and increase in size until they are approximately 100-150 µm in 
diameter.
204-206 
In addition, the cells build and store platelet specific components such 
as von Willebrand’s factor receptor (vWFR) and the fibrinogen receptor complex 
gpIIb/IIIa.
16
 After achieving a “yet-to-be-ascertained state of preparedness”
16
, the 
megakaryocytic cytoplasm begins to generate long pseudopodia whose ends get 
decorated with platelet-sized swellings (proplatelets).
207
 The final platelets are 
released from the ends of the pseudopodia due to shear forces in the bone marrow or 
the pulmonary circulation (Figure 2).
208,209 
During this process, each megakaryocyte 
releases hundreds to thousands of platelets into the pulmonary circulation. All 
platelets vary in shape and in density of the different storage components depending 
on the distribution of these within the mother megakaryocyte.
201
 In cultivated 
megakaryocytic cell lines, incubation with thrombopoeitin or phorbol myristate 





4.3 Platelet Activation 
After injury to blood vessels, a haemostatic plug is formed consisting predominately 
of platelets that undergo a process called activation. Generally, there are three phases 
of platelet activation (primary haemostasis) that stop bleeding within seconds to 








Figure 4.2: Primary haemostasis and its three phases of platelet activation 




The initial phase of platelet activation is platelet adhesion in which platelets bind to 
sub-endothelial matrix proteins like collagen, von Willebrand’s factor (vWF) or 
fibrinonectin which are exposed after injury.
210,211
 Artificial surfaces such as vascular 
grafts that can bind protein stimuli for platelets (e.g. collagen or vWF) can also 
initiate adherence. In this case, the amount and distribution of adsorbed proteins 
depends on the artificial surface and has an impact on platelet adhesion.
212,213
  
In the second step of platelet activation, self-association of platelets into a plug can 
be observed - the so called platelet aggregation step. Thereby, fibrinogen interacts 
with the fibrinogen receptor complex gpIIb/IIIa on the platelet surface. This is 
Platelets 
1. Platelet Adhesion 
2. Platelet Aggregation 
3. Secretion of Granule 
Content 









enabled by high calcium concentration, which holds the glycoprotein complex 
together and enables the binding to fibrinogen.
210,214
  
In the last step of primary haemostasis, the platelets’ granule contents are released 
into the extracellular space. The two major granules in platelets are the dense and α-
granules which contain specific mediators (e.g. adenosine diphosphate (ADP)) and 
proteins (like vWF or fibrinogen) that contribute to stable platelet plug formation.
215-
217 
For further stabilisation of the platelet plug, proteins in the blood plasma 
(coagulation factors), respond in a complex cascade to form fibrin strands, which 
strengthen the platelet plug. This process is called secondary haemostasis and takes 









































In this cascade thrombin is the central enzyme which is responsible for the 
conversion of fibrinogen into fibrin. It can be generated in two ways: the intrinsic 
and the extrinsic pathway. While the extrinsic pathway is initiated by tissue 
thromboplastin - exposed after tissue injuries - the intrinsic pathway is set off when 
foreign surfaces cause complex interactions with the four proteins known as the 
“contact system”: factor XII, XI, high-molecular-weight kininogen (HMWK) and 
prekallikrein (PK). In the end, factor XII is processed into XIIa and starts the 
VIIa             VII
XII       XIIa
XI            XIa
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coagulation cascade. Since the contact system proteins are always present in blood, 
this pathway is called intrinsic.
207,220 
To ensure that fibrin and thrombin are generated 
only at the site of injury, antiproteases circulate throughout the system or are bound 
to endothelial cells and neutralise activated coagulation proteases.
207 
In the last phase 
of stable clot formation (tertiary haemostasis), the fibrin monomers are associated 
into protofibrils and finally into long fibrils. Factor XIIIa cross-links the fine fibrils 




4.4 Current Haemostats  
Several techniques have been developed to support natural haemostasis in case of 
severe injuries where it is crucial to minimise blood loss efficiently. Conventional 
techniques such as ligatures and tourniquets can be labour intensive and are not very 
effective in controlling bleeding in case of complex injuries or where the access of 
the area of bleeding is difficult.
221
 Topical haemostatic agents are useful in these 
situations. They can be classified according to their basic component causing 
coagulation.  
 
Collagen-based Agents  
Since the 1970s bovine collagen-based agents have been used to seal wounds.
222
 As 
described in Chapter 4.2.1 platelets recognise collagen fibrils, adhere to them and get 
aggregated.
223,224 
To enhance to the coagulation result, these agents are commonly 
combined with a procoagulant substances such as thrombin. As the used collagen is 
67 
 
derived from bovine, foreign body responses can be caused and the use of thrombin 




Fibrin-based Agents  
Fibrin-based agents consist of human fibrinogen combined with thrombin plus 
further coagulation factors and/ or compounds that stabilize clots.
226 
By mixing the 
different components, an insoluble fibrin matrix is formed via the final common 
pathway (Chapter 4.1.2).
227,228 
The characterisation of the fibrin sealants depend on 
the fibrinogen concentration: higher concentration give stronger sealants which form 
slower clots. As fibrin-based agents use pooled human plasma products, there is 
always a risk of blood borne pathogen transmissions. Despite screening of blood 
donors and various purifications and viral inactivation processes, paravirus B19 
transmissions via fibrin based agents have been reported.
229 
Moreover, the use of 





The first material specially tailored for bleeding control was oxidized cellulose. The 
haemostatic effect is caused by blood absorption, surface interactions with proteins 
and platelets and activation of both the intrinsic and extrinsic pathways.
230
 In 
addition, it has bacteriostatic properties due to the acid groups (low pH).
231 
Despite 
having been used for decades, it is known to cause immune responses and can also 
cause postoperative neurological complications such as impairment in motor or 






Inorganic Agents  
The best investigated inorganic haemostat is QuikClot (Z-Medica, USA), which is 
based on zeolite.
235
 The mechanism of action is related to the absorption of water 
from the bleeding site. Thereby the concentration of platelets and clotting factors is 
increased, leading to an immediate stop of bleeding. As this process is exothermic, 
cauterization- effects might take place as well, sealing local blood vessels but also 





So far there have been polymer dressings on the market, which consist of liquid 
absorbing hydrogels which expand to occlude the wound and create backpressure to 
stop bleeding.
237
 Polyethylene glycol (PEG)-based agents are currently under 




4.5 Identification of Platelet Activating Polymers Applying Polymer 
Microarray Technology 
For the identification of polymers that activate platelets in a rapid and effective 
manner, polymer microarray studies were carried out. To ensure that the 
investigations would be reliable and accurate and that the platelets would not be 
activated by the agarose background of the arrays, preliminary studies were carried 





 As shown in Figure 4.4a, adhesion of platelets on the agarose 
slide was very poor in comparison to those coated with collagen I (positive control, 
Figure 4.4b).  
. 
          
Figure 4.4: Phase contrast images of PRP incubated on dip coated slides for 30 min. 
a) Agarose, b) Collagen type I. On agarose slides few platelets adhered, while on 
collagen many platelets adhered and became aggregated. Bar scale =100 µm. 
 
Thus, analysis of polymer microarrays would be possible with only a negligible 
background of platelet activation and with only the polymer samples themselves 
being the source for any adhesion/ activation. The positive control (collagen I) was 
placed on the slides by dip coating the end of the polymer microarray into the protein 
solution. Interestingly, studies showed that collagen contact printed onto the agarose 
did not lead to platelet binding. This was rationalised by the fact that the collagen 
was buried in the agarose coating or due to the inability to form the triple helical 
structure necessary for recognition by platelets.
220,238
 Employing the polymer 
microarray approach, 291 polyacrylates (with sixteen replicates) were simultaneously 
tested for platelet adhesion (cell-surface interaction) and aggregation (cell-cell 
interaction). For this purpose the microarrays were incubated with PRP for 30 min, 
                                                 
 
 All work with blood components were carried out by the author in the laboratory facilities of Dr. 




washed in PBS and the bound platelets were stained with the antibodies CD41-FITC 
and CD62P-PE. The antibody CD41 was used as a marker for a general identification 
and quantification of the platelets on the polymer spots as it recognises gpIIb which 
is present on all platelet membranes.
239
 In contrast, CD62P (P-selectin) is only 
present on the outside of the platelet membrane after activation and was used to 
check if the platelet binding polyacrylates activated the platelets.
240
 In Figure 4.5 the 
fluorescence intensity of platelet binding on polymer spots is depicted in relative 
comparison to the positive control collagen (the numeric data for the positive 
(collagen) and negative (agarose) control were obtained by measuring 64 randomly 
selected sites of the same size as the polymer spots).  
Figure 4.5: Relative fluorescence intensity measured on the polymer spots after 
incubation with PRP for 30 minutes and staining with CD41-FITC. The positive 
control collagen I was set to 100%. The depicted results were obtained from three 
independent polymer microarrays each with 16 polymer replicates incubated on 
different dates with platelets from different blood donors. The error bars give the 
standard deviation. Reproducibility of all data was confirmed via one-way ANOVA 
(p < 0.05).  
71 
 
The best polymer PA395 showed a fourfold increase in platelet binding in 
comparison to collagen. Closer examination of the composition of the polymers 
revealed that all platelet binding polymers contained a monomer with a sterically 
non-hindered tertiary amine (which will be protonated at physiological pH) (Table 
4.1). Increases in the level of the tertiary amine monomer (within the same 
polyacrylate combination) led to a significantly higher platelet binding, underlining 
its crucial part in the activation process. For instance, PA393 containing 10% of the 
tertiary amine monomer and 90% ethylmethacrylate gave rise to a 2.5 fold increase 
in platelet binding in comparison to collagen. In contrast, PA395 consisting of the 
same monomers as PA393 but with 50% ethylmethacrylate and 50% of the tertiary 
amine was 3.5 times better than collagen. In the case of PA345 and PA346, the 
opposite effect was observed - the lower amine containing polyacrylate led to higher 
platelet binding. The potential reason for this phenomenon might be twofold. Firstly, 
the polymers containing two tertiary amines per monomer, give a very high charge 
density at lower compositions and ratios (Table 4.1). Moreover, the alcohol group in 











Table 4.1: Composition of platelet binding polyacrylates. 






PA345   90:10 
PA346   70:30 
PA363   90:10 







PA382   70:30 
PA383   50:50 
PA393   90:10 
PA395   50:50 




The different platelet binding capabilities between collagen and the identified 
polymers could be easily observed via fluorescence microscopy (Figure 4.6). 
Figure 4.6: Fluorescence images of collagen and polymers after being incubated for 
30 min with PRP and stained with CD41-FITC and CD62P-Pe. Collagen and PA395 
bind platelets successfully; PA326 does not show any platelet adhesion. The dashed, 




In all cases where platelet adhesion was observed, both antibodies, CD41-FITC and 
CD62P-Pe, bound, indicating that all platelet binding polymers give rise to 
activation, as does collagen. These images also underline the varying amounts of 
platelets that are bound to collagen and the identified polyacrylates. In the case of 
collagen, the platelets were observed to bind in small patches, while the polyacrylate 
PA395, which showed a fourfold increase of platelet binding, gave a dense platelet 
network with less space between the single particles (Figure 4.6). In the case of the 
platelet non-binding polymers such as PA326, platelet adhesion was comparable to 
the agarose background. 
 
4.6 Analysis of Activation State in Static and Flow Experiments 
The different activation states of the platelets indicate how effective the materials are 
in inducing adhesion and aggregation. Under static conditions, a “single-stage 
aggregation” can be assumed where stable aggregations occur between shape-
changed platelets.
241,242 
This means that the materials causing the highest activation 
response leads over time to secondary activation and recruitment of platelets and thus 
to an enhanced haemostatic effect. In static experiments, PRP was incubated on 
polymer coated coverslips for 30 min and the concrete state of activation was 
investigated via scanning electron microscopy. The description of the activation 
status was carried out according to the investigations by Goodman.
241
 In Figure 4.7a, 
the platelet response to collagen (positive control) is shown. The platelets have 
mostly a dendritic shape with some flattened pseudopodia. In contrast, the negative 
control bovine serum albumin (BSA) does not show any obvious platelet binding 
75 
 
which underlines that the samples were not activated beforehand (Figure 4.7b). Some 
polymers, such as PA395, showed results similar to collagen I (Figure 4.7c). The 
platelets were mostly dendritic or pseudopodial, forming a lot of aggregates. 
However, they seemed to be significantly larger and complex on the polymer. Other 
polyacrylates such as PA406 (Figure 4.7d) gave fully spread-out platelets where the 
fluid portion of the cytoplasm (hyaloplasm) was spread between the pseudopodia in a 
way that the pseudopodia could not be defined any more. Fibrin clots, being part of 
the second step of haemostasis, could also be seen for PA383 (Figure 4.7e). Here, the 
material leads to uniform, high activation of the cells and it can be assumed that in 
accordance with the “single-stage aggregation” theory, more platelets bound over 
time to the fully activated platelets.
241,242
 (Representative images for all other 
polymers and platelet activations can be seen in Appendix Figure 2). 
 
Figure 4.7: Scanning electron microscope images of platelets incubated for 30 min 
a b 
c d e 
76 
 
on different substrates. a) Collagen Type I, b) BSA, c) PA395, d) PA406, e) PA383. 
The activation state of the platelets varies between collagen (dendritic cells), 
polymer PA395 (dendritic clusters) and the polyacrylates PA406 and PA383 (fully 
spread cells). In case of PA383 (e) fibrin clot formation as part of the second 
haemostasis step is visible.  
 
In Table 4.2 an overview of the different platelet activation states on the different 
polyacrylates is given. It is worth noting that the number of platelets that bound to 
the different polymers does not indicate the activation state of the platelets. As can be 
seen (Figure 4.7, Table 4.2) collagen and the highest platelet binding polymer PA395 
gave rise to a so-called “dendritic platelet” morphology.
49
 In contrast, polyacrylate 
PA406 which showed comparable binding capability to collagen, gave “fully spread 
out platelets”.  
To simulate the physiological milieu of platelets in a better manner, cone and 
plate(let) studies were carried out, in which PRP and whole blood samples or red 
blood cells are exposed to a shear rate of 1800 s
-1
 for 4 min which simulates pseudo 
physiological flow (Figure 4.8).
243,244
 
Figure 4.8: Principle of cone and plate(let) studies. A mixture of red blood cells and 
PRP is rotated on top of the polymer or collagen coated coverslips. After washing 




To test the effect of the identified polymers on the platelets under these conditions, 
polymer or collagen coated coverslips were placed in the analysis well of the cone 
and platelet instrument and the surface coverage and aggregate size of the platelets 
were determined following the rotation (Table 4.2, Appendix Figure 3). 
Table 4.2: Platelet activation states in static experiments (by scanning electron 
microscopy) and surface coverage, aggregate size under physiologic flow (n=10). 



































11.1 ± 1.5 
14.1 ± 2.3* 
12.4 ±1.5 
12.6 ± 0.7* 
13.8 ± 2.0* 
14.6 ± 3.3* 
10.1 ± 1.6 
14.0 ± 1.5* 
12.4 ± 3.1 
13.4 ± 1.8* 
13.6 ± 1.5* 
14.1 ± 0.9* 
15.0 ± 1.3* 
64.2 ± 15.5 
73.4 ± 9.4 
83.8 ± 19.1* 
75.7 ± 11.1 
90.3 ± 18.8* 
74.8 ± 10.7 
74.0 ± 18.6 
80.4 ± 14.4* 
82.4 ± 16.0* 
83.3 ± 18.9* 
78.8 ± 14.4* 
82.5 ± 17.9* 
91.9 ±16.1* 
 
                                                 







The collagen coated coverslips, representing the natural agonist, resulted in a surface 





Figure 4.9: Impact R test images showing the different surface coverage and 
aggregation sizes depending on the substrates. a) Collagen (surface coverage: 11%, 
aggregate size: 57 µm
2
); b) Polyacrylate PA406 (surface coverage: 15%, aggregate 
size: 102 µm
2
), c) PA406 incubated with red blood cells, without platelet rich plasma 
(surface coverage: 2.3%, aggregate Size: 76 µm
2
), d) PA406 incubated with plasma 





Most of the high-lighted polyacrylates resulted in a higher surface coverage than 
collagen with up to 15% coverage (PA406, Figure 4.9b). The lowest value of surface 
coverage was observed for PA371 (10.1%), which was in accord with the static 
microarray tests where it also showed a slightly lower binding than collagen (Figure 
4.5). Polyacrylates PA345 and PA382 gave comparable platelet binding values to 
collagen on the cone and plate analyzer (surface coverage of 12.4%). In general, the 
aggregate sizes on the identified polymers varied between 79 and 91 µm
2





significantly larger than on collagen (64 µm
2
) implying enhanced platelet activation 
and recruitment. PA363, PA380, PA383, PA393, PA395 and PA406 displayed high 
values for surface coverage and aggregation size under conditions of physiological 
flow and thus might well be suited for the rapid and complete activation of platelets. 
This outcome was expected from the static microarray studies for the polyacrylates 
PA383, PA393 and PA395 where they showed between 1.5 - 3.5 fold higher platelet 
binding. In contrast, the polymers PA380 and PA406 gave comparable results to 
collagen in the static studies. The reason for the improved binding capability might 
of PA380 and PA406 under flow conditions might be due to a slightly different 
aggregation process at shear rates between 1000 and 10000 s
-1
 which involves 
additional receptors and ligands for platelet aggregation and adhesion.
242
 Also, the 
interaction of platelets with the red blood cells might play an important role which 
was not considered in the static experiments. This might be especially the case for 
PA406 which gave even better results than PA395 - the best polymer in the 
microarray studies - for surface coverage as well as aggregation size. Shear rate 
studies without PRP that were carried out with red blood cells or plasma showed 
only few and small aggregates. This proved that the determined aggregates resulted 
from platelet adhesion and aggregation and not from the binding of other blood 









4.7 Activation Mechanism of Polymers 
The mechanism involved in platelet activation and binding on biomaterials is still 
contentious.
242,245
 The prevalent theory is that under static conditions platelet 
aggregations are predominantly mediated by the interaction of fibrinogen with the 
activated platelet integrin receptor gpIIb/IIIa. For this, fibrinogen has to bind to the 
artificial biomaterial, undergo a conformation change which leads to the final 
recognition by platelets and the initiation of the coagulation cascade.
246
 Further 
proteins such as vWF also support binding of platelets and lead to activation. In 
contrast, serum albumin is a protein which should not affect platelet binding and 
activation, indeed it was less likely to be predominantly adsorbed on the platelet-
activating polymers as this would hinder further recruitment of platelet-activating 
proteins. On the basis of this theory, the polymers, which showed successful platelet 
binding, were incubated with platelet poor plasma samples for 30 min. Thereafter, 
they were washed and stained with antibodies against fibrinogen, vWF and serum 
albumin. In Figure 4.10, the corresponding images after incubation with conjugated 




Figure 4.10: Protein adhesion of studies of bovine serum albumin, vWF and 
fibrinogen  on “hit” polyacrylates visualised via antibody staining.  
 
All polymers, except for PA383, did not bind serum albumin, which suggests that the 
polyacrylates are relatively selective in their protein binding affinities.
247
 Adsorption 
of vWF and fibrinogen was observed on most polyacrylates, while some polymers 
such as PA100 and PA346 showed simultaneously binding of fibrinogen and vWF. 
Interestingly, the polymers PA363, PA393 and PA406 did not show any binding for 
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the tested proteins, although the polymeric structure of PA363 and PA393 are 
strongly related to the fibrinogen binding polymers PA364 and PA395, respectively 
(Table 4.2). Since these polyacrylates also lead to platelet aggregation and activation 
(Figure 4.6 and 4.7), the mechanism for this might be either via direct recognition by 
the platelets’ receptors for collagen, fibrinogen or vWF e.g. or by recruitment of 
other proteins that can lead to platelet activation (such as fibrinonectin which 
promotes/ supports platelet adhesion).
248
 Since the coagulation and the complement 
system are highly interlinked, material-induced complement activation might also 

































4.8 Conclusions for Platelet Activation 
A high-throughput microarray procedure has been developed which allowed an 
investigation of platelet binding to potential biomaterials in a qualitative and 
quantitative manner. This method enabled the simultaneous screening of 291 
different polyacrylates under the identical conditions, using minimum amounts of 
PRP. Out of this screen, twelve polyacrylates could be identified that showed 
comparative or higher platelet binding than the natural agonist collagen. Scanning 
electron microscopy studies gave further insights into the activation state of the 
platelets upon binding with polymers showing pronounced binding and a large 
spread out morphology, and shear rate studies allowed verification of the haemostatic 
value of the different polyacrylates. The basis for the haemostatic effect of most 
polymers could be found in the adsorption of proteins such as fibrinogen and vWF 
which leads to the recognition and adherence and aggregation of the platelets. The 
best polyacrylate in this study was PA406 (poly(n-butyl methacrylate-co-
(dimethylamino)ethyl methacrylate (70:30)) as it lead to fully activated and spread 
platelets in the static experiments and outperformed collagen in the shear studies by 
giving significant higher surface coverage (15% vs. 11%) and aggregates about a 
third larger in size (92 µm
2
 vs. 64 µm
2
). Due to the rapid and complete activation of 








4.9 Megakaryocytic Cell Lines 
As described in Chapter 4.7, human megakaryocytes are the giant precursor cells for 
platelets. As they present less than 0.1% of bone marrow cells and are therefore hard 
to collect and cultivate in large numbers, a variety of megakaryocytic cell lines have 
been established.
251,252 
One of the most widely studied is the megakaryblastic 
leukaemia cell line MEG-01, which has been extensively used as model for 
megakaryocytic maturation and platelet formation.
253-256 
Upon incubation with 
megakaryocytic stimuli such as thrombopoietin (TPO), phorbol 12-myristate 13-
acetate (PMA), 12-O-tetradecanoylphorbol-13-acetate (TPA) or Interleucin-6 the 
maturation process of the MEG-01 cell line can be increased. During this maturation 
process, the MEG-01 cells become multi-nucleated and they adhere and extend 
pseudopodia.
255,257-259 
The differentiation pathway for megakaryocytes and 
erythrocytes are strongly related to each other as both cell lineages share a common 










Figure 4.11: The developmental pathway for blood cells. The haematopoietic stem 
cell generates common progenitor cells for lymphoid and for myeloid cells. Upon 
further maturation, progenitor cells for megakaryocytes and erythrocytes as well as 
progenitor cells for granulocytes and monocytes are formed.  
 
The bivalent maturity state of the common progenitor cell of megakaryocytes and 
erythrocytes can be compared to the erythroleukemic cell line K562 which expresses 
cell-specific markers of both cell types and which can undergo further differentiation 
into the specific lineage depending on the applied stimuli.
262-267 
Similar to the cell 
line MEG-01, cellular changes in morphology and adherence properties can be 
observed after differentiation towards the megakaryocytic lineage is initiated.
264
  
To facilitate the collection and cultivation process of human megakaryocytes, 
substrates would be of interest that could capture cells specifically out of complex 
samples (bone marrow or blood) without having a major impact on cellular 
differentiation. By using the cell lines MEG-01 and K562, the biomaterial could also 
be tested for megakaryocyte specificity. 
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4.10 Polymers Sorting Megakaryocytic Cell Lines 
For the identification of polymers that could lead to the adhesion of the cell line 
MEG-01, polymer microarrays with 813 polymers - polyurethanes and polyacrylates 
- were fabricated by contact printing of preformed polymer solutions. The natural 
protein collagen served as a positive control. Polystyrene was used as a negative 
binding control since normally only a few suspension cells adhere to this material.
253
 
Polymer microarray studies were also carried out with the erythroid cell line K562 to 
identify polymers that specifically bind cells of the megakaryocytic lineage. For 
quantification of cellular binding, the cells were fixed, the nuclei stained with the 
fluorescent dye Hoechst 33342  and counted after fixation (Figure 4.12a, b). 
Polymers which only bound MEG-01 cells and not K562 cells were classified as 















Figure 4.12: Microarray binding studies. a) Brightfield and fluorescence microscopy 
images of quadruplicate PA382 polymer spots showing binding of MEG-01 cells 
stained with Hoechst 33342. Scale Bar = 100 µm; b) Comparison of MEG-01 and 
K562 binding on polystyrene, collagen and the hit polymers for MEG-01 cells after 4 
days of incubation (n = 2 with 8 replicates). Grey-MEG-01, black-K562.  
 
While cellular binding for MEG-01 cells on polystyrene was low (100 cells/mm
2
), 
the positive control collagen showed an attachment of approximately 900 cells/mm
2 
for both cell lines, K562 and MEG-01. Five synthetic polymers (PA382, PA112, 
PA346, PA00 and PA96) were identified that showed enhanced cell binding of 
MEG-01 cells in comparison to polystyrene (Figure 4.12b). Polymer PA395 is shown 
as a representative for polymers that did not increase MEG-01 cell binding in 
comparison to polystyrene (100 cells/mm
2
). The best polymer for binding MEG-01 
cells was PA382 with 900 cells/mm
2
, comparable to collagen. However, like the 
natural protein, the polymer also bound K562 cells, showing that it was non-specific 




increase in MEG-01 cell binding in comparison to polystyrene with both polymers 
being specific for the megakaryocytic lineage.
 
 
As shown in Table 4.3, all identified polymers that bound MEG-01 cells contained 
monomers with secondary amino groups. However, as PA395 gave strong adherence 
of K562 cells in contrast to MEG-01 cells, the secondary amine content must not be 
the only criteria for binding MEG-01 cells. 
 
Table 4.3: Chemical compositions of the identified polyacrylates. Polymers listed 
showed enhanced MEG-01 cell binding in comparison to polystyrene except for 
PA395, which represents a structure of a non-binding polycrylate for megakaryocytic 
cells. 




























4.11 Morphology and Protein Binding Studies 
The top polymers were explored for their effect on cellular morphology and cellular 
proliferation of MEG-01 cells on polymer coated coverslips via brightfield and 
scanning electron microscopy (Figure 4.13). The morphology of MEG-01 cells on 
PA382 was representative for all polyacrylates except for PA112. The round, 
suspension cell-like morphology with numerous microvilli on the cells’ surfaces 
resembled in its appearance adherent K562.
137 
Most MEG-01 cells cultivated on 
these polyacrylates did not have any pseudopodia (Figure 4.13). In the case of 
PA112, the adherent MEG-01 cells were characterised by a “rounded” morphology 
(similar to the one for PA382) as well as an “outstretched” structure with long 
pseudopodia forming proplatelets and leading to platelet-like particle formation 
(Figure 4.13). These adherent cells resemble the mature status of MEG-01 cells on 





Figure 4.13: MEG-01 cell binding on PA382, PA112 and polystyrene after 4 d of 
incubation. MEG-01 cells adhered on PA382 were small and of round morphology, 
partly with short pseudopodia extruding. On polystyrene, the MEG-01 cells had lost 
their round morphology (less suspension cell like) and also showed clear maturated 
cells with long pseudopodia and proplatelets. The cells adhered on PA112 were a 
mixture of the cells shown for PA382 and polystyrene. Brightfield Images: scale bars 
= 100 µm; scanning electron microscopy: scale bars = 10 µm. 
 
To gain a deeper understanding of the binding mechanisms for the identified 
polyacrylates, protein binding studies were carried out. Polymer coated coverslips 
that showed successful MEG-01 cell binding were incubated in fully supplemented 
RPMI medium for 16 h, washed with PBS and the binding proteins were stripped off 
the polymers by boiling in sodium dodecyl sulfate (SDS). All polymers gave protein 
bands for the same protein mixture with serum albumin as major component (Figure 
4.14). Interestingly in all studies, polystyrene (PS) and PA112 bound less of the 
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adhered proteins. This suggests that the protein binding content is crucial for the 
adherence of MEG-01 cells and its morphology – a higher content of protein bound 
to the polymers led to a round suspension cell like morphology, while the cells had 
an outstretched morphology in the case of polymers binding less proteins. (as shown 
in Figure 4.13 and Figure 4.14).   
 
Figure 4.14: Representative protein gel used to analyse the “amount” and type of 
proteins that bound to polymers after 24 h. While all MEG-01 binding polymers 
bound a large variety of proteins, polystyrene (PS) binds only three different proteins 
– serum albumin, hemoglobin and alpha-2HS-glycoprotein (n = 4 with 2 replicates).  
 
 
4.12 Influence on Maturation and Gene Regulation 
To investigate if the identified polyacrylates affected the differentiation/ maturation 
of the adhered cells, flow cytometry studies were carried out. After 4 d incubation of 
the MEG-01 cell line on the different polymer substrates, the adhered cells were 
collected and stained with antibodies for the maturation markers CD41 and CD42b, 
which are characteristic for the cell-specific megakaryocytic progenitor cells and 
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fully mature megakaryocytes. As control MEG-01 cells that were in suspension and 
cultivated in polystyrene tissue flasks were used. The ratio of the cells in the different 
maturation states, analysed by their expression of CD41 and CD42b antigens, did not 





Table 4.4: Flow Cytometry Studies of polymer bound MEG-01 cells stained with 
CD41 after 4 d incubation on different polymer substrates. The number given is the 
percentage of 10000 cells positive for CD41 (standardderivation, n=3 in duplicates). 
 
Substrate CD41 [%] CD42b [%] 
Polystyrene 16±3 2±1 
PA 96 8±6 2±2 
PA100 6±4 5±5 
PA112 12±4 4±1 
PA346 12±3 3±1 
PA382 10±3 2±1 
 
 
To further investigate if polymer immobilisation had an influence on the adhered 
MEG-01 cells, the miRNA fingerprint of cells cultivated on polystyrene was 





 As shown in Figure 4.15, MEG-01 cells cultivated on polystyrene, PA112 
and PA382 showed a very good correlation (94% and 70%), proving that the gene 
regulation was not or only to a minor extent influenced by the immobilisation.  
 
Figure 4.15: Pairwise plot (log2) with sample correlation for polystyrene, PA112 
and PA382. Similarities and differences between the three datasets are indicated, 
showing that between polystyrene and PA112 one single miRNA is changed in 
regulation (correlation 94%). The difference between PA382 and polystyrene to 




Interestingly, five human miRNAs were found to be highly up-regulated in cells 
cultivated on PA382 in comparison to polystyrene and PA112 (Table 4.5). Most of 
these miRNAs are known to regulate genes that are responsible for cellular adhesion, 
migration and apoptosis. These events are important in the course of the maturation 
                                                 

 The miRNA array kits were kindly provided by Dr. Juraj Petrik. The computational analysis of the 
miRNA arrays was carried out by Samuel Corless in the research group of Dr. Nick Gilbert 
(University of Edinburgh). 
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process of the megakaryoblastic cell line MEG-01 and may give a hint how PA382 
effects the maturation process which might not be observable via flow cytometry 
within a short incubation time (4 d). 
 
Table 4.5: Up-regulated human miRNAs (x5) and their putative targets in MEG-01 








hsa-miR-129-5p ETV1, PAPD5, SGCD, 
RUNX1T1, SOX4 
Cell growth, Differentiation, 
Proliferation, 
Polyadenylation of miRNA, 
ECM Structure, Apoptosis  
hsa-miR-602 LRPAP1, BCL2L13, 
C5AR1, KLHK24, CUX1 
Apoptosis, Differentiation, 
Cell Cyle Progression, 
Chemotaxis 





Cellular Adhesion and 
Migration  






hsa-miR-1469 BAIAP3, FEZF2  Brain-specific Proteins 




However, for confirmation of the upregulation of the identified genes, further 
experiments have to be carried out such as qPCR with the specific primers for the 























4.13 Conclusion for Sorting of Megakaryocytic Cells 
Polymer microarrays were successfully used for the identification of polymers that 
bind MEG-01 cells. By extending the cellular binding studies to K562 cells, which 
have both erythroid and megakaryocytic markers, two polymers, PA112 (poly(2-
methoxyethyl acrylate-co-(2-tert-butylamino)ethyl methacrylate) (70:30)) and 
PA346 (poly(methyl acrylate-co-(dimethylamino)propyl (methylamino)-2-propanol 
methacrylate) (70:30)) were identified which are specific for the megakaryocytic 
lineage. Analysis of MEG-01 cell morphology on the different polymers showed that 
most polymers bound cells in a round, suspension cell-like form with few and only 
short pseudopodia. In contrast, PA112 bound cells displaying an “outstretched” 
morphology with long pseudopodia forming proplatelets as could be seen for mature 
cells on polystyrene. Analysis of the proteins binding to the artificial polymers 
indicated a possible link between quantity of bound protein mixture to the cellular 
morphology. Immobilisation had only a minor influence on the cellular gene 
regulation as shown by miRNA studies and flow cytometry. 
The identified polymers offer the opportunity to enrich and sort megakaryocytic cells 
from bone marrow suspensions but also to modify the polymeric structure with 








Chapter 5: Experimental 
5.1 General Information 
5.1.1 Equipment 
Instruments for Microarray fabrication  
SciFLEXARRAYER S5 inkjet printer (Scienion AG, Germany)  
Microdrop inkjet printer (microdrop Technologies GmbH, Germany) 
Qarray
mini
 contact printer (Genetix, UK) 
Vacuum oven Vacutherm VT6025 (Heraeus, Germany) 
Oxygen plasma (Europlasma, Belgium). 
 
Special Microscopes and Scanner 
Philips XL30CP Scanning electron microscope (Koninklijke Philips Electronics 
N.V., Netherlands) 
Veeco Atomic Force Microscope Multimode/Nanoscope IIIa (Veeco, Canada)  
Bioanalyzer 4F/4S white light scanner with FIPS software (LaVision BioTech, 
Germany)  
Nikon 50i fluorescence microscope with automated stage and Pathfinder
TM
 software 
(IMSTAR S.A., France). 
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Cell Culture  
Incubator HERAcell 150 (Heraeus, Germany) 
Biosafety cabinet HERAsafe KS 18 class II (Heraeus, Germany) 
 
5.1.2 Microscope Slides and Coverslips  
Microscope glass slides: 76 x 26 mm (Menzel GmbH Co. KG, Germany) 
Round coverslips :13 mm in diameter (Menzel GmbH Co. KG, Germany) 
 
5.1.3 Chemicals and Solvents  
All chemicals and solvents unless otherwise stated were purchased from Sigma 
Aldrich (UK). Collagen Type I (PureCol®) was received from Advanced Biomatrix 
Inc. (USA). Phosphate buffered saline (PBS, pH 7.4) was purchased from Oxoid 
(UK). Osmium tetroxide and 0.1 M cacodylate buffer (pH 7.4) containing 2.5% 
glutaraldehyde were purchased from Electron Microscopy Sciences (USA). Trideca-
fluoro-1,1,2,2-tetrahydrooctyl-dimethylchlorosilane (FDS) was purchased from abcr 
GmbH Co. KG (Germany). 
 
5.1.3 Polymer Libraries  
The polyacrylate and polyurethane libraries were synthesised in our laboratory as 
part of previous projects.
272,273
 All members of the libraries were characterised by gel 
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permeation chromatography, contact angle measurements and FT-IR (Mattson 
Instrument, USA) as previously described.
272,273
















5.2 Experimental for Chapter 2 
5.2.1 Preparation of Acrylate Functionalised Masks  
Microscope glass slides (76 x 26 mm) were cleaned in sodium hydroxide (1 M) for 2 
h and afterwards rinsed with water and acetone. As a mask, spots of 2 drops 20% 
aqueous sucrose solution (w/w) were printed at 400 µm distances onto the slides 
using a microdrop inkjet printer. The sucrose printed slides were coated with trideca-
fluoro-1,1,2,2-tetrahydrooctyl-dimethylchlorosilane (FDS, 5 µL) for 12 h in a sealed 
box. After removing the sugar spots with water and acetone, the slides were 
incubated with a solution of 3-(trimethyoxysilyl)propyl methacrylate (TMSA, 10 µL) 
for 12 h. Finally, the slides were washed with water and acetone and the solutions 
needed for the in situ polymerization were printed on the former sugar sites. 
 
5.2.2 Inkjet Printing for In Situ Formation of Polymer Spots 
In situ polymerization was achieved by printing two individual acrylate monomer 
solutions (20% (w/v) in 1-methyl-2-pyrrolidinone (NMP)), the crosslinker 1,4-
butanediol diacrylate (30% (w/v) in NMP) and the photoinitiator 1-
hydroxycyclohexyl phenyl ketone (30% (w/v) in NMP) on a drop-by-drop basis with 
a sciFLEXARRAYER S5. After half of the array was printed (3658 spots), the array 
was cooled on dry ice and irradiated with UV light for 20 min. Thereafter, the print 
was continued as before and finished with a second UV light application (20 min) 
under cooling. To ensure hardening of the polyacrylates and to evaporate all solvent 
traces, the arrays were incubated at 50 °C overnight. Thereafter, the array was rinsed 
101 
 
with ethanol leaving successful polymerized spots on the array and washing away 
any unpolymerised material.  
 
5.2.3 Preparation of Polymer Coated Coverslips 
Coverslips (13 mm in diameter) were cleaned in sodium hydroxide (1 M) for 16 h 
and afterwards rinsed with water and acetone. After having been air dried, the 
coverslips were incubated with a solution of 2% (v/v) TMSA and 0.5% (v/v) 
ethylendiamine in acetonitrile for 16 h. After washing with acetonitrile and 
acetonitrile, the coverslips were dried on air and stored until polymer coating at -20 
°C. For polymer coating, monomer, crosslinker and photoinitiator solutions in NMP 
were spread onto coverslips and exposed to UV light (Model B 100AP, Black-Ray) 
for 30 min. After incubation at 50 °C for 16 h, the coverslips were rinsed with 
ethanol. Prior cell cultivation, the coverslips were sterilsed with UV light for 15 min 
and washed with PBS. 
 
5.2.4 Scanning Electron Microscopy (SEM) and energy dispersive X-ray 
spectroscopy (EDX) 
The printed polymer microarrays were gold coated using a Bal-Tec SCD050 sputter 
coater (Leica Microsystems GmbH, Germany) and secondary electron (SE) images 
of the microarrays were captured with a Philips XL30CP scanning electron 
microscope using an accelerating voltage of 20kV.  
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For the energy dispersive X-ray spectroscopy, a microarray consisting of the 
monomers 2-hydroxyethyl methacrylate and ethylene glycol methacrylate phosphate 
was fabricated and carbon coated with a Denton BTT-IV carbon evaporation coater 
(Denton Vacuum LLC, USA). An X-ray map was collected for carbon, oxygen and 
the phosphorous over the whole spot area for 60 min to verify its uniformity using 
the PGT Spirit ED system on the above microscope. For this investigation an 
accelerating voltage of 10 kV beam was used. 
 
5.2.5 Water Contact Angle Measurements 
Water drops of 5 µL in volume were deposited on the substrates using a micro-
syringe. Images of the drops were captured with a CCD (Flee 2, Point Grey Research 
Camera, Canada) camera operating at 60 fps. A white LED backlight with diffuser 
was used to ensure uniform lighting and good contrast. The drop shape analysis 
software from First Ten Angstroms (USA) was used to determine the contact angles 
once the droplets reached a steady state. Assuming drop axisymmetry, the contact 
angles were measured (n=5).  
 
5.2.6 Atomic Force Microscopy 
Polymer coated coverslips were imaged with atomic force microscopy under ambient 
conditions using a Veeco AFM, Multimode/Nanoscope IIIa equipped with a J-
scanner (x-y-range of 140 µm). The images were recorded in tapping mode using 
RTESP Veeco cantilevers with a nominal sprint constant and a resonance frequency 
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of 40 N/m and 300 kHz. The set-point amplitude ratio rsp = Asp/ A0 was kept close 
to 1 (where Asp is the reduced scanning set-point amplitude and A0 stands for the 
free oscilation amplitude). This ensured a “light tapping” where the interaction force 
between the tip and the substrate was minimized without losing contact. Areas of 4 
µm
2
 were recorded and the root mean square roughness (RMS) was measured across 
this region. Image processing was conducted with the software Scanning Probe 
Image Processor (SPIP, Image Metrology, Denmark). 
 
5.2.7 Cell Culture 
The hESC line RH1 used in this study was described previously.
94 
The cell line was 
derived under an HFEA license (No. R0136) permitting the use of donated embryos 
in research, the creation of embryos and the derivation of human embryonic stem 
cells. Full informed consent for research use was obtained in advance from the donor 
couple. The RH1 cell line was cultured on growth factor reduced Matrigel
TM
 (Becton 
Dickinson, UK), in chemically defined medium mTESR 1 (Stem Cell Technologies, 
France) and passaged using a collagenase/ scraping regime. For incubation on the 
microarrays, RH1 hESC were treated with collagenase for 5 min at 37 °C and the 
cells manually detached from Matrigel
TM
 plates with a scraper. Cell lumps were 
broken down by pipetting and the cells plated on the sterilized and PBS washed array 
at a concentration of 1.2 million cells/array. After an incubation time of 4 d, with 
daily media change, the cells were fixed with paraformaldehyde in PBS (4 %, (v/v)) 
and the cells stained with DAPI and Oct-4 antibody labeled with FITC. 
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For the incubation on coverslips, the RH1 cell line was seeded at a concentration of 
60 000 cells/coverslip. After approx. 7 d the cells were confluent and were passaged 
by treatement with trypsin (0.025 % (v/v)) for 2 min and following suspension in 
mTESRI supplemented with p160-Rho-associated coiled kinase (ROCK) inhibitor 
(1:10). The cells were seeded at a concentration of 60000 cells/coverslip in mTESRI 
medium supplemented with ROCK inhibitor. The following daily medium changes 
were carried out with mTESRI medium without further supplements. 
 
5.2.8 Cell population Doubling Time 
The cell population doubling time was calculated by counting the cells before and 
after passaging. The cell doubling time was estimated as an exponential function and 




5.2.9 Immunocytochemistry of hESCs on Polymer Coverslips 
Cells were stained using a standard immunocytochemistry protocol. Briefly, hESCs 
on polymers were washed once with PBS and fixed with 4% (v/v) paraformaldehyde 
in PBS. After permeabilisation with 0.2% (v/v) Igepal (Sigma-Aldrich, USA) and 
blocking in 10% (v/v) normal rabbit serum (Millipore), cells were incubated with 
primary antibodies (Oct-4 (1:50, Santa Cruz Biotechnology, USA), Nanog (1:30, 
R&D systems, USA), for 2-4 hours at room temperature or overnight at 4C. 
Visualisation with secondary antibodies was performed using Alexafluor antibodies 
488 and 555, (Invitrogen, USA) and nuclei were stained with DAPI. Imaging 
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analysis was carried out using a fluorescence microscope Leica DM IRB equipped 
with a DFC 350 FX camera (Leica Microsystems CMS GmbH, Germany) 
 
5.2.10 Flow Cytometry Analysis 
Cells were dissociated by incubation with 0.025% (v/v) trypsin/EDTA for 5-10 min 
at 37 °C, resuspended in FACS PBS (PBS supplemented with 0.1% (v/v) BSA and 
0.1% (v/v) sodium azide) and incubated with preconjugated antibodies (SSEA-4- 
FITC; SSEA-1-PE (all from BioLegend, USA) and in FACS PBS for 20-40 min. 
Data were obtained using a FACS calibur and analysed using FlowJo 7.6.3. (TreeStar 
















5.3 Experimental for Chapter 3 
5.3.1 Preparation of Masked Glass Slides  
Microscope glass slides (76 x 26 mm) were cleaned with sodium hydroxide (1 M) for 
2 h and then rinsed with water and acetone. The slides were masked by printing 25 
spots (each 3 drops) of 20% aqueous sucrose solution (w/v) 200 µm apart in 3 
columns (each column 200 µm apart) using a microdrop inkjet printer (Microdrop 
Technologies GmbH, Germany). The distance between the single spots allowed the 
spots to merge together to form a line. The masked slides were treated with 
(tridecafluoro-1,1,2,2-tetrahydrooctyl) dimethylchlorosilane (5 µL) for 12 h in a 
sealed box. After removing the sucrose masking by washing the slides with water 
and acetone, the exposed slide surfaces were coated with 3-
(trimethyoxysilyl)propylmethacrylate (10 µL) for 16 h. Finally, the slides were 
washed with water and acetone and stored at -20 °C until use. 
 
5.3.2 Inkjet Printed Gradients  
Gradients were generated by printing acrylate monomers (20% (w/v) in NMP), a 
crosslinker (1,4-butanediol diacrylate, 30% (w/v) in NMP) and the photoinitiator (1-
hydroxycyclohexyl phenyl ketone, 30% (w/v) in NMP) on a drop-by-drop basis 
(sciFLEXARRAYER S5, Scienion AG, Germany). For the printing of 5 mm long 
and 0.5 mm wide lines, six spots each of 26 drops (400 pL per droplet) were printed 
800 µm apart. The drop ratio of Monomer A:Monomer B varied from 19:0 to 15:4, 
12:8, 8:12, 4:15 and 0:19, with a final crosslinker concentration per spot of 6% (5 
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drops) and a final photoinitiator concentration of 2% (2 drops). Depending on the 
length and width of the gradients, the number of drops of the different components 
was changed accordingly (SI Table 1). 
A fluorous coated slide, (tridecafluoro-1,1,2,2-tetrahydrooctyl) dimethylchlorosilane 
coated microscope slide) was placed on top of the printed array. Compression 
allowed the merging of the spots to give the gradient-line prior to UV irradiation 
(Black Ray® Model B 100,) for 15 min. The slides were kept at 50 °C overnight to 
ensure complete polymerisation and were then rinsed with ethanol to remove non-
polymerised material. For visualisation purposes, a gradient of 2-diethyl amine 
acrylate and (2-hydroxyethyl methacrylate with 1% (w/v) 5(6)-carboxyfluorescein) 
was prepared and the fluorescent gradient analysed using a Bioanalyzer 4F scanner. 
 
5.3.3 X-Ray Photoelectron Spectroscopy  
XPS analysis of the phosphorous 2p signal intensity was carried out with a VG 
Sigma Probe spectrometer using Al Kα radiation with a 30 μm diameter spot (1.5 
W), a pass energy of 100 eV and a 0.5 eV step size on a polymer gradient prepared 
from the monomers 2-hydroxyethyl methacrylate and ethylene glycol methacrylate 
phosphate. 
 
5.3.4 Cell Culture  
Cell lines: Human erythroleukaemic cells (K562) and human cervical cancer cells 
(HeLa) were grown in RPMI 1640 growth medium supplemented with heat 
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inactivated fetal bovine serum (FBS) (10% v/v), penicillin (100 U mL
-1
), 
streptomycin (100 mg mL
-1
) and L-glutamine (4 mM) at 37 °C with 5% CO2. Media, 
serum and antibiotics were purchased from (Gibco, UK) or (Sigma-Aldrich, UK). 
Prior to incubation with 5x10
5
 cells/array, the gradient polymer microarrays were 
sterilized with UV light for 15 min. After an incubation time of 3 d, cells were fixed 
with paraformaldehyde in PBS (4%, (v/v)) and cells stained with propidium iodide (1 
µg/mL). In case of OGPCS, the cells were incubated for 18 h on the slides till the 
slides were fixed and mounted. 
Primary Cells: OGPCS were obtained by following the protocol described by 
McCarthy.
170
 Forebrains of neonatal rat pups were removed, stripped of meninges 
and then mechanically and enzymatically dissociated. The resulting cell suspension 
was plated onto Poly-D-lysine coated Falcon 75 cm
2
 cell culture flasks in culture 
medium consisting of DMEM supplemented with 10% (w/v) FBS with 1% (w/v) 
penicillin and streptomycin and incubated at 37 °C and 7.5% CO2. Culture medium 
was changed after 24 h and twice weekly thereafter. Prior to incubation on the 
gradient polymer microarrays (750000 cells/array), the arrays were sterilised by 10 
min exposure to UV light on either side. Microglia were incubated on the slides and 
incubated at 37 °C, 7.5% CO2 for 18 h before being fixed in 4%  (v/v) 
paraformaldehyde in PBS and stained with Hoechst 33342 (1 µg/mL). 
 
5.3.5 Image Acquisition and Analysis 
K562, HeLa: Stained cells were imaged using a Leica fluorescence microscope DM 
IRB equipped with a DFC 350 FX camera (Leica Microsystems CMS GmbH, 
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OGPCS: Images were taken from the two ends of the gradient lines with a Zeiss 





5.3.6 Modification of Gradients with 6-Aminofluorescein 
Polymer gradients of N-acryloxysuccinimide and 2-hydroxyethyl methacrylate were 
fabricated and after polymerisation, washed with hexane. Gradient derivatisation was 
achieved by a 2 h incubation with 6-aminofluorescein (300 µL, 1 mg/mL in dry 
DMF). After washing the slide with DMF and water, fluorescence analysis was 
carried out with a Bioanalyzer 4F scanner. 
 
5.3.7 Modification of Gradients with Semaphorin 3F 
Polymer gradients of 2-carboxyethyl methacrylate and tert-butyl acrylate or tert-
butylcyclohexyl acrylate were fabricated and after polymerisation, washed with 
hexane. Gradient derivatisation was achieved incubating the arrays with 300 µL of a 
mixture of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, 0.1 M) and N-
hydroxysuccinimide (5 mM) in dry DMF for 2 h. This was followed by coupling of 




5.3.8 Protein Gradient Verification: Fluorescence Intensity Measurement 
The fluorescence of each gradient was calculated by measuring the fluorescence at 
15 circular areas of interest (AOI, diameter = 50 pixels) along each line from both 
pre- and post - incubation with semaphorin antibodies using Bioanalyzer 4F. The 
score from the pre-incubation AOIs could then be subtracted as background to give 




















5.4 Experimental for Chapter 4 
5.4.1 Platelets and Red Blood Cells 
Two-day-old buffy coat-derived, pooled and leuco-reduced, citrated platelet rich 
plasma (PRP) was obtained from the Scottish National Blood Transfusion Service 
(SNBTS). It was stored at 22 °C with agitation. Flow cytometry studies were carried 
out prior to the microarray tests to ensure minimal activation and consistent platelet 
contents. Platelet poor plasma (PPP) was prepared by two centrifugations of the PRP 
samples at 1700 g for each 15 min and collecting the supernatant. Red blood cells 
were obtained from the SNBTS components processing laboratories using standard 
blood bank methods. The samples were leuco-reduced on the day of donation and 
stored in a saline, adenine, glucose, mannitol additive (SAGM) at 4 ± 2 °C. All cell 
counts and haematocrit determinations were carried out on a Sysmex KX-21 cell 
counter (Sysmex, UK). 
 
5.4.2 Polymer Microarray Fabrication 
Agarose Coating 
Glass slides were cleaned with an oxygen plasma (Europlasma, Belgium) at 20 °C 
for 5 min and treated with 2 % (w/v) 3-aminopropyltriethoxysilane in acetonitrile for 
1 h. Thereafter, the slides were rinsed with acetonitrile, acetone and dried at 100 °C 
overnight. Agarose coating was achieved by dipping 2/3 of the slides into a 2 % 




Contact Printing of Polymers and Collagen Coating 
Polyacrylates (PA) and polyurethanes (PU) were contact printed with a Qarrayer
mini 
equipped with aQu solid pins (K2785, Genetix). For printing, 1 % (w/v) polymer 
solutions in N-methyl pyrrolidine were used and stamped five times for each spot. 
The inking time was 200 ms, the stamping time 100 ms. Under these conditions, 
typical spot diameters of 300 to 320 µm were achieved. The slides were dried under 
vacuum at 40 °C overnight. The part of the glass slide which was free of agarose, 
was further dip coated into collagen I solution (3 mg/mL) and left overnight at 4 °C 
before being air dried. 
 
5.4.3 Static Microarray PRP Studies and Fluorescence Microscopy 
PRP (300 µL) was directly incubated on the microarray slides for 30 min at room 
temperature. Thereafter, the slides were washed with PBS and fixed with 1 % 
paraformaldehyde for a further 30 min. The slides were rinsed in PBS and incubated 
with a solution of the antibodies CD41-FITC and CD62P-PE (dilution: 1:100 in 
PBS). After 1 h, the slides were washed with PBS, water and air dried. The 
fluorescence intensity of each spot was measured with a Bioanalyzer 4F (LaVision, 
Germany). Images of each polymer spot were captured with a Nikon 50i 
fluorescence microscope using the Pathfinder
TM
 software (IMSTAR S.A., France). 
For adsorption studies of plasma proteins, PPP was incubated on microarrays for 30 
min. The slides were washed twice with PBS and stained with antibodies against 
fibrinogen (sheep anti human fibrinogen-FITC), von Willebrand factor (vWF, sheep 
anti human vWF antibody following an incubation with donkey anti-sheep 
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IgG:Dylight®649) and serum albumin (mouse anti-human serum albumin antibody 
following an incubation with goat-anti mouse IgG-Dylight®549). All antibodies 
were used at dilutions of 1:100 in PBS. After washing the slides in PBS and water, 
the slides were scanned with the Bioanalyzer 4F system. 
 
5.4.4 Upscale of Polymers on Coverslips 
Glass coverslips of 13 mm diameter were cleaned with tetrahydrofuran (THF) and 
spin coated with 2 % (w/v) preformed polymer solutions in THF for 2 s at 2000 rpm. 
The coverslips were dried in a vacuum oven overnight at 40 °C, 200 mbar and 
irradiated with UV light for 20 min prior use in cell studies. As a control, collagen I 
and BSA coverslips were prepared by incubating the aqueous protein solutions (3 
mg/mL) overnight at 4 °C and left to air dry.  
 
5.4.5 Scanning Electron Microscopy 
PRP (100 µL) was incubated on 13 mm coverslips coated with the hit polymers from 
the static microarray experiments for 30 minutes. After washing with PBS, the 
remaining cells on the coverslips were fixed with 2.5 % glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4) for 2 h. After washing twice with 0.1 M cacodylate 
buffer, the samples were post-fixed with 1 % osmium tetroxide for 1 h and 
dehydrated through graded ethanol (50, 70, 90 and 100 %). Finally, the samples were 
critical point dried in CO2 and gold coated by sputtering. Images were captured with 
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a Philips XL30CP scanning electron microscope. For each polymer, five images 
were taken in random areas of the coverslips in two separate experiments. 
 
5.4.6 Shear Studies on the Cone and Platelet Analyser  
Platelet adhesion on 13 mm polymer coated coverslips was carried out under arterial 
flow conditions according to the Cone and Plate(let) principal on an Impact-R 
analyzer (Matis-Medical, Belgium) [22]. A mixture of 0.6 mL PRP and 1 mL of 
ABO-compatible routine leuco-reduced red blood cells in SAGM was rotated at 10 
rpm for 1 min. The resulting mixture had similar levels of platelet counts (300 x 10
3 
cells/µL) and haematocrit (35-45 %) as in whole blood samples except for the 
reduced levels of leucocytes. For the studies, 130 µL of this mixture was placed onto 
the cone equipped with the polymer coated coverslip and rotated at 1800 s
-1
 for 4 
min. The coverslips were washed with distilled water and the adhered platelets were 
stained with 300 µL of May-Grünewald solution for 1 min. The remaining staining 
solution was removed and the coverslips were air-dried. Seven images of the stained 
platelets were captured on defined areas. The surface coverage and aggregate size 
were calculated via the Impact R software (Version: 1.28, DiaMed, USA). All 
samples were run in duplicate and average values obtained (n = 10). 
 
5.4.7 Statistics 
For comparing two data sets the two-tailed, unpaired Student’s-test was applied. For 
data sets more than two the one-way analysis of variance (ANOVA) was calculated. 
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In the calculations, a significant probability of 95 % was accepted as being 
reasonable (i.e. p < 0.05 is significant).  
 
5.4.8 Megakaryocytic Cell Culture 
The cell strains MEG-01 and K562 were received from the Health Protection 
Agency’s Culture Collection, (London, UK). They were grown in RPMI 1640 
medium supplemented with 10 % FBS (Invitrogen, UK), 2mM L-Glutamine (100 
U/mL of penicillin and 100 µg/mL of streptomycin. The cells were seeded at a 
concentration of 3x10
5
 cells/mL and passaged every three days. 
 
5.4.9 Polymer Microarray Studies 
Cells were washed with PBS and diluted with media to a final concentration of 10
5
 
cells/mL. The polymer microarrays were placed in a four well-plate (Nunc, 
Germany) and 6 mL of the cell solution was gently added into the well. After an 
incubation period of 4 d, the microarray slides were washed with PBS and fixed with 
4 % (v/v) formaldehyde in PBS for 1 h. Then the cells were stained with the nuclear 
stain Hoechst 33342 at a final concentration of 1 µg/mL in PBS for 30 min. When it 
was required to stain the cells with further antibodies, the slides were washed with 
PBS and incubated with the respective antibody solution in PBS for 1 h. At the end 
the, the microarray was washed with PBS and water and finally air dried. Image 
capture was carried out via a Nikon 50i fluorescence microscope using IMSTAR 
Pathfinder
TM




5.4.10 Proteinbinding on Polymer SDS-Page and MS analysis 
Polymer coated coverslips (diameter: 13 mm) were incubated for 1 d in RPMI 
medium supplemented with 10 % FBS, 2mM L-Glutamine and 100 U/mL of 
penicillin and 100 µg/mL of streptomycin (SIGMA-Aldrich, UK). The coverslips 
were washed twice with PBS and the proteins were eluted by boiling in SDS-sample 
buffer (0.5 M Tris-HCl (pH 8.8), SDS 4% (w/v), glycerol 20% (v/v), 2-
mercaptoethanol 2% (v/v), and bromophenol blue 0.0025%) for 5 min. The proteins 
were separated on a mini-PROTEAN TGX 4-20% SDS/PAGE 1D gel in TGS buffer 
(Tris 0.025M, Glycine 0.192M, w/v SDS 0.1%, 200 V, 180 mA, 35 min) stained 
with Coomassie Blue or ProteoSilverTM silver stain and imaged and processed. 
Detected protein bands were reduced with 10 mM DTT, 0.2% EDTA in 100 mM 
ammonium bicarbonate in acetonitrile (AbC) at 56 °C for 30 min followed by 
alkalation with 50 mM iodoacetamide in 100 mM AbC in the dark at room 
temperature for 30 min. After washing the mixture was digested in trypsin buffer (13 
ng trypsin in 50 mM AbC) at 37 °C for 12 h. The digested mixture was analyzed by 
LC-MS/MS (Dionic Ultimate 3000; Solvent A: 98% water, 2% acetonitrile (ACN), 
0.1% formic acid (FA); Solvent B: 80% ACN, 20% water, 0.1% FA; 100 % A 
to100% B in 1 h; MS/MS: Bruker HCT Ultra PTM). The data were analyzed with 
DataAnalysis v.4.0 SP4, BioTools 3.2 SR1 and compared with a protein database 




5.4.11 Flow Cytometry 
The expression of CD41 (GPIIb/IIIa) and CD42b on MEG-01 cells was measured as 
described before.
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 Briefly, MEG-01 cells were cultivated on polymer coverslips for 
4 d. The adherent cells were washed, detached with trypsin (2 min, 1:100 
Trypsin/PBS), washed in medium and PBS (containing 0.1 % BSA) and stained with 
antibodies against anti-human CD41-FITC and CD42b-Pe for 30 min. Subsequently, 
the cells were washed in PBS (0.1% BSA) and analysed in a FACSArier2000 (BD, 
UK). Controls without any antibody and of suspension cells were analysed as well.
  
 
5.4.12 miRNA Array Profiling 
The cell line MEG-01 was washed with PBS and diluted with media to a final 
concentration of 10
5
 cells/mL and incubated on polymer coated coverslips (PA382, 
PA112, diameter: 5 cm) or on 6-well polystyrene culture dishes (Nunc, Germany )for 
4 d. Thereafter, miRNA was extracted with the miRCURY
TM
 RNA Isolation Kit-Cell 
and Plant Version 1.1 (Exiqon, Denmark) according to the protocol provided. The 
cells were counted and about 10
6
 cells were used for miRNA isolation. After 
purification with the provided columns and buffers provided, samples were stored at 
-70 °C until further usage. The quantity of the total RNA was determined with a 
Nanodrop2000 (Thermo Fisher Scientific Inc., USA) and for each sample 0.5 µg of 
total RNA were used for labelling with Hy3
TM 
fluorescent label with the miRCURY 
LNA
TM
 microRNA Array Power Labelling Kit version 3.0 (Exiqon, Denmark) 





 generation, human, mouse and rat (Exiqon, Denmark) which contains 
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control probes and more than 1800 capture probes complementary to human, mouse, 
rat and their related viral sequences registered in the miRBASE version 14.0 at the 
Sanger Institute following the procedure described by the manufacturer. After 
washing, the slides were scanned and image analysis was carried out with Aida 
Image Analyzer version 4.50 (raytest GmbH, Germany). The quantified signals were 
background corrected and normalised using a quantile normalisation. The median of 
each set of identical datapoints (quadruplicates) was calculated to account for the 
variance within the data. The data was re-normalised using a quantile normalisation, 
to account for minor changes introduced by using the medians. From this data 
pairwise comparisons (log2-plots) were generated to show the similarities and 
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Figure 1: Cell binding profile of K562 cells across the polymer gradients as 
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Figure 2: Representative SEM images taken for the different platelet binding 






Figure 3: Impact R test images showing the different surface coverage and 
aggregation sizes of platelets for the diverse polyacrylates as discussed in Chapter 4. 




















MMA    methyl methacrylate 
Ema     ethyl methacrylate 
BMA    butyl methacrylate 
MEMA   2-methoxyethylacrylate 
MEA    2-methoxyethylacrylate 
HEMA   2-hydroxyethyl methacrylate 
HPMA   hydroxypropyl methacrylate 
HBMA   hydroxybutyl methacrylate 
DEAAm   N,N-diethylacrylamide 
DMAAm   N,N-dimethylacrylamide 
NIPAAm   N-isopropyl acrylamide 
DAAA  diacetone acrylamide 
DMAPMAAm  N,N-dimethylaminopropyl acrylamide 
DEAEAMA   2-(diethylamino)ethyl methacrylate 





DEAEA   2-(diethylamino)ethyl acrylate 
DMAEA   2-(dimethylamino)ethyl acrylate 
MTEMA   2-(methylthio)ethyl methacrylate 
BAEMA   2-(tert-butylamino)ethyl methacrylate 
BACOEA   2-[[(butylamino)carbonyl]oxy]ethylacrylate 
MNPMA   2-methyl-2-nitropropyl methacrylate 
DMVBA  N,N-dimethylvinylbenzylamine 
VAA    N-vinylacetamide 
VI   1-vinylimidazole 
VPNO   1-vinyl-2-pyrrolidinone 
VP-4   4-vinylpyridine 
VP-2    2-vinylpyridine 
A-H   acrylic acid 
AES-H      mono-2-(acryloyloxy)ethyl succinate 
MA-H   methacrylic acid 
AAG-H   2-acrylamidoglycolic acid 



















Amines for Functionalisation 
GMA    glycidyl methacrylate 
DnBA   di-n-butylamine 
DnHA   di-n-hexylamine 
DcHA    dicyclohexylamine 
DBnA    dibenzylamine 
MnHA   N-methylhexylamine 
cHMA   cyclohexanemethylamine 
BnMA   N-benzylmethylamine 
MAEPy   2-(2-methylaminoethyl)pyridine 
Pyrrole   pyrrole 
Man    n-methylaniline 
TMEDA   N,N,N’-trimethylethylenediamine 
DEMEDA  N,N-diethyl-N’-methylethylenediamine 
TMPDA   N,N,N’-trimethyl-1,3-propanediamine 
Mpi    1-methylpiperazine 



















Table 1: List of polyacrylates in the polyacrylate library used. 
Polyacrylate 
ID number 
Polymer Composition Monomer 
Ratios 
Monomer Type 














1 St DEAA - 90 10 - CON - 
2 St DEAA - 70 30 - CON - 
3 St DEAA - 50 50 - CON - 
4 St DMAA - 90 10 - CON - 
5 St DMAA - 70 30 - CON - 
6 St DMAA - 50 50 - CON - 
7 St PAA - 90 10 - CON - 
8 St PAA - 70 30 - CON - 
9 St PAA - 50 50 - CON - 
10 MMA DEAA - 90 10 - CON - 
11 MMA DEAA - 70 30 - CON - 
12 MMA DEAA - 50 50 - CON - 
13 MMA DMAA - 90 10 - CON - 
14 MMA DMAA - 70 30 - CON - 
15 MMA DMAA - 50 50 - CON - 
16 MMA PAA - 90 10 - CON - 
17 MMA PAA - 70 30 - CON - 
18 MMA PAA - 50 50 - CON - 
19 MEMA DEAA - 90 10 - CON - 
20 MEMA DEAA - 70 30 - CON - 
21 MEMA DEAA - 50 50 - CON - 




23 MEMA DMAA - 70 30 - CON - 
24 MEMA DMAA - 50 50 - CON - 
25 MEMA PAA - 90 10 - CON - 
26 MEMA PAA - 70 30 - CON - 
27 MEMA PAA - 50 50 - CON - 
28 MEA DEAA - 90 10 - CON - 
29 MEA DEAA - 70 30 - CON - 
30 MEA DEAA - 50 50 - CON - 
31 MEA DMAA - 90 10 - CON - 
32 MEA DMAA - 70 30 - CON - 
33 MEA DMAA - 50 50 - CON - 
34 MEA PAA - 90 10 - CON - 
35 MEA PAA - 70 30 - CON - 
36 MEA PAA - 50 50 - CON - 
37 HEMA DEAA - 90 10 - CON - 
38 HEMA DEAA - 70 30 - CON - 
39 HEMA DEAA - 50 50 - CON - 
40 HEMA DMAA - 90 10 - CON - 
41 HEMA DMAA - 70 30 - CON - 
42 HEMA DMAA - 50 50 - CON - 
43 HEMA PAA - 90 10 - CON - 
44 HEMA PAA - 70 30 - CON - 
45 HEMA PAA - 50 50 - CON - 
46 HPMA DEAA - 90 10 - CON - 
47 HPMA DEAA - 70 30 - CON - 
48 HPMA DEAA - 50 50 - CON - 




50 HPMA DMAA - 70 30 - CON - 
51 HPMA DMAA - 50 50 - CON - 
52 HPMA PAA - 90 10 - CON - 
53 HPMA PAA - 70 30 - CON - 
54 HPMA PAA - 50 50 - CON - 
55 HBMA DEAA - 90 10 - CON - 
56 HBMA DEAA - 70 30 - CON - 
57 HBMA DEAA - 50 50 - CON - 
58 HBMA DMAA - 90 10 - CON - 
59 HBMA DMAA - 70 30 - CON - 
60 HBMA DMAA - 50 50 - CON - 
61 HBMA PAA - 90 10 - CON - 
62 HBMA PAA - 70 30 - CON - 
63 HBMA PAA - 50 50 - CON - 
         
96 MEMA DEAEMA - 90 10 - NH2 - 
97 MEMA DEAEMA - 70 30 - NH2 - 
98 MEMA DEAEMA - 50 50 - NH2 - 
99 MEMA DMAEMA - 90 10 - NH2 - 
100 MEMA DMAEMA - 70 30 - NH2 - 
101 MEMA DMAEMA - 50 50 - NH2 - 
102 MEMA DEAEA - 90 10 - NH2 - 
103 MEMA DEAEA - 70 30 - NH2 - 
104 MEMA DEAEA - 50 50 - NH2 - 
105 MEMA DMAEA - 90 10 - NH2 - 
106 MEMA DMAEA - 70 30 - NH2 - 




108 MEMA MTEMA - 90 10 - RSR - 
109 MEMA MTEMA - 70 30 - RSR - 
110 MEMA MTEMA - 50 50 - RSR - 
111 MEMA BAEMA - 90 10 - NH2 - 
112 MEMA BAEMA - 70 30 - NH2 - 
113 MEMA BAEMA - 50 50 - NH2 - 
114 MEMA DMAPMAA - 90 10 - NH2, 
CON 
- 
115 MEMA DMAPMAA - 70 30 - NH2, 
CON 
- 
116 MEMA DMAPMAA - 50 50 - NH2, 
CON 
- 
117 MEMA BACOEA - 90 10 - CON - 
118 MEMA BACOEA - 70 30 - CON - 
119 MEMA BACOEA - 50 50 - CON - 
120 MEMA DMVBA - 90 10 - NH2 - 
121 MEMA DMVBA - 70 30 - NH2 - 
122 MEMA DMVBA - 50 50 - NH2 - 
123 MEMA VAA - 90 10 - CON - 
124 MEMA VAA - 70 30 - CON - 
125 MEMA VAA - 50 50 - CON - 
126 MEMA VI - 90 10 - Aromatic - 
127 MEMA VI - 70 30 - Aromatic - 
128 MEMA VI - 50 50 - Aromatic - 
129 MEMA VPNO - 90 10 - CON - 
130 MEMA VPNO - 70 30 - CON - 




132 MEMA VP-4 - 90 10 - Aromatic - 
133 MEMA VP-4 - 70 30 - Aromatic - 
134 MEMA VP-4 - 50 50 - Aromatic - 
135 MEMA VP-2 - 90 10 - Aromatic - 
136 MEMA VP-2 - 70 30 - Aromatic - 
137 MEMA VP-2 - 50 50 - Aromatic - 
138 MEMA DAAA - 90 10 - CON - 
139 MEMA DAAA - 70 30 - CON - 
140 MEMA DAAA - 50 50 - CON - 
141 MEMA MNPMA - 90 10 - Nitro - 
142 MEMA MNPMA - 70 30 - Nitro - 
143 MEMA MNPMA - 50 50 - Nitro - 
         
150 HEMA DEAEMA - 90 10 - NH2 - 
151 HEMA DEAEMA - 70 30 - NH2 - 
152 HEMA DEAEMA - 50 50 - NH2 - 
153 HEMA DMAEMA - 90 10 - NH2 - 
154 HEMA DMAEMA - 70 30 - NH2 - 
155 HEMA DMAEMA - 50 50 - NH2 - 
156 HEMA DEAEA - 90 10 - NH2 - 
157 HEMA DEAEA - 70 30 - NH2 - 
158 HEMA DEAEA - 50 50 - NH2 - 
159 HEMA DMAEA - 90 10 - NH2 - 
160 HEMA DMAEA - 70 30 - NH2 - 
161 HEMA DMAEA - 50 50 - NH2 - 
162 HEMA MTEMA - 90 10 - RSR - 




164 HEMA MTEMA - 50 50 - RSR - 
165 HEMA BAEMA - 90 10 - NH2 - 
166 HEMA BAEMA - 70 30 - NH2 - 
167 HEMA BAEMA - 50 50 - NH2 - 
168 HEMA DMAPMAA - 90 10 - NH2, 
CON 
- 
169 HEMA DMAPMAA - 70 30 - NH2, 
CON 
- 
170 HEMA DMAPMAA - 50 50 - NH2, 
CON 
- 
171 HEMA BACOEA - 90 10 - CON - 
172 HEMA BACOEA - 70 30 - CON - 
173 HEMA BACOEA - 50 50 - CON - 
174 HEMA DMVBA - 90 10 - NH2 - 
175 HEMA DMVBA - 70 30 - NH2 - 
176 HEMA DMVBA - 50 50 - NH2 - 
177 HEMA VAA - 90 10 - CON - 
178 HEMA VAA - 70 30 - CON - 
179 HEMA VAA - 50 50 - CON - 
180 HEMA VI - 90 10 - Aromatic - 
181 HEMA VI - 70 30 - Aromatic - 
182 HEMA VI - 50 50 - Aromatic - 
183 HEMA VPNO - 90 10 - CON - 
184 HEMA VPNO - 70 30 - CON - 
185 HEMA VPNO - 50 50 - CON - 
186 HEMA VP-4 - 90 10 - Aromatic - 




188 HEMA VP-4 - 50 50 - Aromatic - 
 
189 HEMA VP-2 - 90 10 - Aromatic - 
190 HEMA VP-2 - 70 30 - Aromatic - 
191 HEMA VP-2 - 50 50 - Aromatic - 
192 HEMA DAAA - 90 10 - CON - 
193 HEMA DAAA - 70 30 - CON - 
194 HEMA DAAA - 50 50 - CON - 
195 HEMA MNPMA - 90 10 - Nitro - 
196 HEMA MNPMA - 70 30 - Nitro - 
197 HEMA MNPMA - 50 50 - Nitro - 
198 MMA A-H - 90 10 - COOH - 
199 MMA A-H - 70 30 - COOH - 
200 MMA A-H - 50 50 - COOH - 
201 MMA AES-H - 90 10 - COOH - 
202 MMA AES-H - 70 30 - COOH - 
203 MMA AES-H - 50 50 - COOH - 
204 MMA MA-H - 90 10 - COOH - 
205 MMA MA-H - 70 30 - COOH - 
206 MMA MA-H - 50 50 - COOH - 
207 MMA AAG-H - 90 10 - COOH - 
208 MMA AAG-H - 70 30 - COOH - 
209 MMA AAG-H - 50 50 - COOH - 
210 MMA EGMP-H - 90 10 - COOH - 
211 MMA EGMP-H - 70 30 - COOH - 
212 MMA EGMP-H - 50 50 - COOH - 




214 MEMA A-H - 70 30 - COOH - 
215 MEMA A-H - 50 50 - COOH - 
216 MEMA AES-H - 90 10 - COOH - 
217 MEMA AES-H - 70 30 - COOH - 
218 MEMA AES-H - 50 50 - COOH - 
219 MEMA MA-H - 90 10 - COOH - 
220 MEMA MA-H - 70 30 - COOH - 
221 MEMA MA-H - 50 50 - COOH - 
222 MEMA AAG-H - 90 10 - COOH - 
223 MEMA AAG-H - 70 30 - COOH - 
224 MEMA AAG-H - 50 50 - COOH - 
225 MEMA EGMP-H - 90 10 - COOH - 
226 MEMA EGMP-H - 70 30 - COOH - 
227 MEMA EGMP-H - 50 50 - COOH - 
228 MMA A-H DEAEMA 70 20 10 COOH NH2 
229 MMA A-H DEAEMA 70 15 15 COOH NH2 
230 MMA A-H DEAEMA 70 10 20 COOH NH2 
231 MMA A-H DEAEA 70 20 10 COOH NH2 
232 MMA A-H DEAEA 70 15 15 COOH NH2 
233 MMA A-H DEAEA 70 10 20 COOH NH2 
234 MMA MA-H DEAEMA 70 20 10 COOH NH2 
235 MMA MA-H DEAEMA 70 15 15 COOH NH2 
236 MMA MA-H DEAEMA 70 10 20 COOH NH2 
237 MMA MA-H DEAEA 70 20 10 COOH NH2 
238 MMA MA-H DEAEA 70 15 15 COOH NH2 
239 MMA MA-H DEAEA 70 10 20 COOH NH2 




241 MEMA A-H DEAEMA 70 15 15 COOH NH2 
242 MEMA A-H DEAEMA 70 10 20 COOH NH2 
243 MEMA A-H DEAEA 70 20 10 COOH NH2 
244 MEMA A-H DEAEA 70 15 15 COOH NH2 
245 MEMA A-H DEAEA 70 10 20 COOH NH2 
246 MEMA MA-H DEAEMA 70 20 10 COOH NH2 
247 MEMA MA-H DEAEMA 70 15 15 COOH NH2 
248 MEMA MA-H DEAEMA 70 10 20 COOH NH2 
249 MEMA MA-H DEAEA 70 20 10 COOH NH2 
250 MEMA MA-H DEAEA 70 15 15 COOH NH2 
251 MEMA MA-H DEAEA 70 10 20 COOH NH2 
252 MEMA GMA - 90 10 - Epoxy - 
253 MEMA GMA - 70 30 - Epoxy - 
254 MEMA GMA - 50 50 - Epoxy - 
255 MEMA GMA DnBA 90 10 - OH NH2 
256 MEMA GMA DnBA 70 30 - OH NH2 
257 MEMA GMA DnBA 50 50 - OH NH2 
258 MEMA GMA DnHA 90 10 - OH NH2 
259 MEMA GMA DnHA 70 30 - OH NH2 
260 MEMA GMA DnHA 50 50 - OH NH2 
261 MEMA GMA DcHA 90 10 - OH NH2 
262 MEMA GMA DcHA 70 30 - OH NH2 
263 MEMA GMA DcHA 50 50 - OH NH2 
264 MEMA GMA DBnA 90 10 - OH NH2 
265 MEMA GMA DBnA 70 30 - OH NH2 
266 MEMA GMA DBnA 50 50 - OH NH2 




268 MEMA GMA MnHA 70 30 - OH NH2 
269 MEMA GMA MnHA 50 50 - OH NH2 
270 MEMA GMA cHMA 90 10 - OH NH2 
271 MEMA GMA cHMA 70 30 - OH NH2 
272 MEMA GMA cHMA 50 50 - OH NH2 
273 MEMA GMA BnMA 90 10 - OH NH2 
274 MEMA GMA BnMA 70 30 - OH NH2 
275 MEMA GMA BnMA 50 50 - OH NH2 
276 MEMA GMA MAEPy 90 10 - OH NH2 
277 MEMA GMA MAEPy 70 30 - OH NH2 
278 MEMA GMA MAEPy 50 50 - OH NH2 
279 MEMA GMA Pyrle 90 10 - OH NH2 
280 MEMA GMA Pyrle 70 30 - OH NH2 
281 MEMA GMA Pyrle 50 50 - OH NH2 
282 MEMA GMA 2-MAPy 90 10 - OH NH2 
283 MEMA GMA 2-MAPy 70 30 - OH NH2 
284 MEMA GMA 2-MAPy 50 50 - OH NH2 
285 MEMA GMA MAn 90 10 - OH NH2 
286 MEMA GMA MAn 70 30 - OH NH2 
287 MEMA GMA MAn 50 50 - OH NH2 
288 MEMA GMA TMEDA 90 10 - OH NH2 
289 MEMA GMA TMEDA 70 30 - OH NH2 
290 MEMA GMA TMEDA 50 50 - OH NH2 
291 MEMA GMA DEMEDA 90 10 - OH NH2 
292 MEMA GMA DEMEDA 70 30 - OH NH2 
293 MEMA GMA DEMEDA 50 50 - OH NH2 




295 MEMA GMA TMPDA 70 30 - OH NH2 
296 MEMA GMA TMPDA 50 50 - OH NH2 
297 MEMA GMA Mpi 90 10 - OH NH2 
298 MEMA GMA Mpi 70 30 - OH NH2 
299 MEMA GMA Mpi 50 50 - OH NH2 
300 MEMA GMA TEDETA 90 10 - OH NH2 
301 MEMA GMA TEDETA 70 30 - OH NH2 
302 MEMA GMA TEDETA 50 50 - OH NH2 
303 MMA GMA - 90 10 - Epoxy - 
304 MMA GMA - 70 30 - Epoxy - 
305 MMA GMA - 50 50 - Epoxy - 
306 MMA GMA DnBA 90 10 - OH NH2 
307 MMA GMA DnBA 70 30 - OH NH2 
308 MMA GMA DnBA 50 50 - OH NH2 
309 MMA GMA DnHA 90 10 - OH NH2 
310 MMA GMA DnHA 70 30 - OH NH2 
311 MMA GMA DnHA 50 50 - OH NH2 
312 MMA GMA DcHA 90 10 - OH NH2 
313 MMA GMA DcHA 70 30 - OH NH2 
314 MMA GMA DcHA 50 50 - OH NH2 
315 MMA GMA DBnA 90 10 - OH NH2 
316 MMA GMA DBnA 70 30 - OH NH2 
317 MMA GMA DBnA 50 50 - OH NH2 
318 MMA GMA MnHA 90 10 - OH NH2 
319 MMA GMA MnHA 70 30 - OH NH2 
320 MMA GMA MnHA 50 50 - OH NH2 




322 MMA GMA cHMA 70 30 - OH NH2 
323 MMA GMA cHMA 50 50 - OH NH2 
324 MMA GMA BnMA 90 10 - OH NH2 
325 MMA GMA BnMA 70 30 - OH NH2 
326 MMA GMA BnMA 50 50 - OH NH2 
327 MMA GMA MAEPy 90 10 - OH NH2 
328 MMA GMA MAEPy 70 30 - OH NH2 
329 MMA GMA MAEPy 50 50 - OH NH2 
330 MMA GMA Pyrle 90 10 - OH NH2 
331 MMA GMA Pyrle 70 30 - OH NH2 
332 MMA GMA Pyrle 50 50 - OH NH2 
333 MMA GMA 2-MAPy 90 10 - OH NH2 
334 MMA GMA 2-MAPy 70 30 - OH NH2 
335 MMA GMA 2-MAPy 50 50 - OH NH2 
336 MMA GMA MAn 90 10 - OH NH2 
337 MMA GMA MAn 70 30 - OH NH2 
338 MMA GMA MAn 50 50 - OH NH2 
339 MMA GMA TMEDA 90 10 - OH NH2 
340 MMA GMA TMEDA 70 30 - OH NH2 
341 MMA GMA TMEDA 50 50 - OH NH2 
342 MMA GMA DEMEDA 90 10 - OH NH2 
343 MMA GMA DEMEDA 70 30 - OH NH2 
344 MMA GMA DEMEDA 50 50 - OH NH2 
345 MMA GMA TMPDA 90 10 - OH NH2 
346 MMA GMA TMPDA 70 30 - OH NH2 
347 MMA GMA TMPDA 50 50 - OH NH2 




349 MMA GMA Mpi 70 30 - OH NH2 
350 MMA GMA Mpi 50 50 - OH NH2 
351 MMA GMA TEDETA 90 10 - OH NH2 
352 MMA GMA TEDETA 70 30 - OH NH2 
353 MMA GMA TEDETA 50 50 - OH NH2 
354 MMA DEAEMA - 90 10 - NH2 - 
355 MMA DEAEMA - 70 30 - NH2 - 
356 MMA DEAEMA - 50 50 - NH2 - 
357 MMA DMAEMA - 90 10 - NH2 - 
358 MMA DMAEMA - 70 30 - NH2 - 
359 MMA DMAEMA - 50 50 - NH2 - 
360 MMA DEAEA - 90 10 - NH2 - 
361 MMA DEAEA - 70 30 - NH2 - 
362 MMA DEAEA - 50 50 - NH2 - 
363 MMA DMAEA - 90 10 - NH2 - 
364 MMA DMAEA - 70 30 - NH2 - 
365 MMA DMAEA - 50 50 - NH2 - 
366 HPMA DEAEMA - 90 10 - NH2 - 
367 HPMA DEAEMA - 70 30 - NH2 - 
368 HPMA DEAEMA - 50 50 - NH2 - 
369 HPMA DMAEMA - 90 10 - NH2 - 
370 HPMA DMAEMA - 70 30 - NH2 - 
371 HPMA DMAEMA - 50 50 - NH2 - 
372 HPMA DEAEA - 90 10 - NH2 - 
373 HPMA DEAEA - 70 30 - NH2 - 
374 HPMA DEAEA - 50 50 - NH2 - 




376 HPMA DMAEA - 70 30 - NH2 - 
377 HPMA DMAEA - 50 50 - NH2 - 
378 HBMA DEAEMA - 90 10 - NH2 - 
379 HBMA DEAEMA - 70 30 - NH2 - 
380 HBMA DEAEMA - 50 50 - NH2 - 
381 HBMA DMAEMA - 90 10 - NH2 - 
382 HBMA DMAEMA - 70 30 - NH2 - 
383 HBMA DMAEMA - 50 50 - NH2 - 
384 HBMA DEAEA - 90 10 - NH2 - 
385 HBMA DEAEA - 70 30 - NH2 - 
386 HBMA DEAEA - 50 50 - NH2 - 
387 HBMA DMAEA - 90 10 - NH2 - 
388 HBMA DMAEA - 70 30 - NH2 - 
389 HBMA DMAEA - 50 50 - NH2 - 
390 EMA DEAEMA - 90 10 - NH2 - 
391 EMA DEAEMA - 70 30 - NH2 - 
392 EMA DEAEMA - 50 50 - NH2 - 
393 EMA DMAEMA - 90 10 - NH2 - 
394 EMA DMAEMA - 70 30 - NH2 - 
395 EMA DMAEMA - 50 50 - NH2 - 
396 EMA DEAEA - 90 10 - NH2 - 
397 EMA DEAEA - 70 30 - NH2 - 
398 EMA DEAEA - 50 50 - NH2 - 
399 EMA DMAEA - 90 10 - NH2 - 
400 EMA DMAEA - 70 30 - NH2 - 
401 EMA DMAEA - 50 50 - NH2 - 




403 BMA DEAEMA - 70 30 - NH2 - 
404 BMA DEAEMA - 50 50 - NH2 - 
405 BMA DMAEMA - 90 10 - NH2 - 
406 BMA DMAEMA - 70 30 - NH2 - 
407 BMA DMAEMA - 50 50 - NH2 - 
408 BMA DEAEA - 90 10 - NH2 - 
409 BMA DEAEA - 70 30 - NH2 - 
410 BMA DEAEA - 50 50 - NH2 - 
411 BMA DMAEA - 90 10 - NH2 - 
412 BMA DMAEA - 70 30 - NH2 - 
413 BMA DMAEA - 50 50 - NH2 - 
414 MEMA DEAEMA MA 40 30 30 NH2 MA 
415 MEMA DEAEMA MA 60 10 30 NH2 MA 
416 MEMA DEAEMA MA 60 30 10 NH2 MA 
417 MEMA DEAEMA MA 80 10 10 NH2 MA 
418 MEMA DEAEA MA 40 30 30 NH2 MA 
419 MEMA DEAEA MA 60 10 30 NH2 MA 
420 MEMA DEAEA MA 60 30 10 NH2 MA 
421 MEMA DEAEA MA 80 10 10 NH2 MA 
422 MEMA DEAEMA BMA 40 30 30 NH2 BMA 
423 MEMA DEAEMA BMA 60 10 30 NH2 BMA 
424 MEMA DEAEMA BMA 60 30 10 NH2 BMA 
425 MEMA DEAEMA BMA 80 10 10 NH2 BMA 
426 MEMA DEAEA BMA 40 30 30 NH2 BMA 
427 MEMA DEAEA BMA 60 10 30 NH2 BMA 
428 MEMA DEAEA BMA 60 30 10 NH2 BMA 




430 MEMA DEAEMA MEA 40 30 30 NH2 MEA 
431 MEMA DEAEMA MEA 60 10 30 NH2 MEA 
432 MEMA DEAEMA MEA 60 30 10 NH2 MEA 
433 MEMA DEAEMA MEA 80 10 10 NH2 MEA 
434 MEMA DEAEA MEA 40 30 30 NH2 MEA 
435 MEMA DEAEA MEA 60 10 30 NH2 MEA 
436 MEMA DEAEA MEA 60 30 10 NH2 MEA 
437 MEMA DEAEA MEA 80 10 10 NH2 MEA 
438 MEMA DEAEMA DEGMEMA 40 30 30 NH2 DEGMEMA 
439 MEMA DEAEMA DEGMEMA 60 10 30 NH2 DEGMEMA 
440 MEMA DEAEMA DEGMEMA 60 30 10 NH2 DEGMEMA 
441 MEMA DEAEMA DEGMEMA 80 10 10 NH2 DEGMEMA 
442 MEMA DEAEA DEGMEMA 40 30 30 NH2 DEGMEMA 
443 MEMA DEAEA DEGMEMA 60 10 30 NH2 DEGMEMA 
444 MEMA DEAEA DEGMEMA 60 30 10 NH2 DEGMEMA 
445 MEMA DEAEA DEGMEMA 80 10 10 NH2 DEGMEMA 
446 MEMA DEAEMA THFFA 40 30 30 NH2 THFFA 
447 MEMA DEAEMA THFFA 60 10 30 NH2 THFFA 
448 MEMA DEAEMA THFFA 60 30 10 NH2 THFFA 
449 MEMA DEAEMA THFFA 80 10 10 NH2 THFFA 
450 MEMA DEAEA THFFA 40 30 30 NH2 THFFA 
451 MEMA DEAEA THFFA 60 10 30 NH2 THFFA 
452 MEMA DEAEA THFFA 60 30 10 NH2 THFFA 
453 MEMA DEAEA THFFA 80 10 10 NH2 THFFA 
454 MEMA DEAEMA THFFMA 40 30 30 NH2 THFFMA 
455 MEMA DEAEMA THFFMA 60 10 30 NH2 THFFMA 




457 MEMA DEAEMA THFFMA 80 10 10 NH2 THFFMA 
458 MEMA DEAEA THFFMA 40 30 30 NH2 THFFMA 
459 MEMA DEAEA THFFMA 60 10 30 NH2 THFFMA 
460 MEMA DEAEA THFFMA 60 30 10 NH2 THFFMA 
461 MEMA DEAEA THFFMA 80 10 10 NH2 THFFMA 
462 MEMA DEAEMA HEA 40 30 30 NH2 HEA 
463 MEMA DEAEMA HEA 60 10 30 NH2 HEA 
464 MEMA DEAEMA HEA 60 30 10 NH2 HEA 
465 MEMA DEAEMA HEA 80 10 10 NH2 HEA 
466 MEMA DEAEA HEA 40 30 30 NH2 HEA 
467 MEMA DEAEA HEA 60 10 30 NH2 HEA 
468 MEMA DEAEA HEA 60 30 10 NH2 HEA 
469 MEMA DEAEA HEA 80 10 10 NH2 HEA 
470 MEMA DEAEMA HEMA 40 30 30 NH2 OH 
471 MEMA DEAEMA HEMA 60 10 30 NH2 OH 
472 MEMA DEAEMA HEMA 60 30 10 NH2 OH 
473 MEMA DEAEMA HEMA 80 10 10 NH2 OH 
474 MEMA DEAEA HEMA 40 30 30 NH2 OH 
475 MEMA DEAEA HEMA 60 10 30 NH2 OH 
476 MEMA DEAEA HEMA 60 30 10 NH2 OH 
477 MEMA DEAEA HEMA 80 10 10 NH2 OH 
478 MEMA DEAEMA A-H 40 30 30 NH2 COOH 
479 MEMA DEAEMA A-H 60 10 30 NH2 COOH 
480 MEMA DEAEMA A-H 60 30 10 NH2 COOH 
481 MEMA DEAEMA A-H 80 10 10 NH2 COOH 
482 MEMA DEAEA A-H 40 30 30 NH2 COOH 




484 MEMA DEAEA A-H 60 30 10 NH2 COOH 
485 MEMA DEAEA A-H 80 10 10 NH2 COOH 
486 MEMA DEAEMA MA-H 40 30 30 NH2 COOH 
487 MEMA DEAEMA MA-H 60 10 30 NH2 COOH 
488 MEMA DEAEMA MA-H 60 30 10 NH2 COOH 
489 MEMA DEAEMA MA-H 80 10 10 NH2 COOH 
490 MEMA DEAEA MA-H 40 30 30 NH2 COOH 
491 MEMA DEAEA MA-H 60 10 30 NH2 COOH 
492 MEMA DEAEA MA-H 60 30 10 NH2 COOH 
493 MEMA DEAEA MA-H 80 10 10 NH2 COOH 
494 MEMA DEAEMA DMAA 40 30 30 NH2 CON 
495 MEMA DEAEMA DMAA 60 10 30 NH2 CON 
496 MEMA DEAEMA DMAA 60 30 10 NH2 CON 
497 MEMA DEAEMA DMAA 80 10 10 NH2 CON 
498 MEMA DEAEA DMAA 40 30 30 NH2 CON 
499 MEMA DEAEA DMAA 60 10 30 NH2 CON 
500 MEMA DEAEA DMAA 60 30 10 NH2 CON 
501 MEMA DEAEA DMAA 80 10 10 NH2 CON 
502 MEMA DEAEMA DAAA 40 30 30 NH2 CON 
503 MEMA DEAEMA DAAA 60 10 30 NH2 CON 
504 MEMA DEAEMA DAAA 60 30 10 NH2 CON 
505 MEMA DEAEMA DAAA 80 10 10 NH2 CON 
506 MEMA DEAEA DAAA 40 30 30 NH2 CON 
507 MEMA DEAEA DAAA 60 10 30 NH2 CON 
508 MEMA DEAEA DAAA 60 30 10 NH2 CON 
509 MEMA DEAEA DAAA 80 10 10 NH2 CON 




511 MEMA DEAEMA MMA 60 10 30 NH2 CH3 
512 MEMA DEAEMA MMA 60 30 10 NH2 CH3 
513 MEMA DEAEMA MMA 80 10 10 NH2 CH3 
514 MEMA DEAEA MMA 40 30 30 NH2 CH3 
515 MEMA DEAEA MMA 60 10 30 NH2 CH3 
516 MEMA DEAEA MMA 60 30 10 NH2 CH3 
517 MEMA DEAEA MMA 80 10 10 NH2 CH3 
518 MEMA DEAEMA St 40 30 30 NH2 Aromatic 
519 MEMA DEAEMA St 60 10 30 NH2 Aromatic 
520 MEMA DEAEMA St 60 30 10 NH2 Aromatic 
521 MEMA DEAEMA St 80 10 10 NH2 Aromatic 
522 MEMA DEAEA St 40 30 30 NH2 Aromatic 
523 MEMA DEAEA St 60 10 30 NH2 Aromatic 
524 MEMA DEAEA St 60 30 10 NH2 Aromatic 
525 MEMA DEAEMA - 85 15 - NH2 - 
526 MEMA DEAEMA - 80 20 - NH2 - 
527 MEMA DEAEMA - 75 25 - NH2 - 
528 MEMA DEAEMA - 70 30 - NH2 - 
529 MEMA DEAEMA - 65 35 - NH2 - 
530 MEMA DEAEMA - 60 40 - NH2 - 
531 MEMA DEAEMA - 55 45 - NH2 - 
532 MEMA A-H DEAEMA 85 5 10 COOH NH2 
533 MEMA A-H DEAEMA 80 5 15 COOH NH2 
534 MEMA A-H DEAEMA 75 5 20 COOH NH2 
535 MEMA A-H DEAEMA 70 5 25 COOH NH2 
536 MEMA A-H DEAEMA 65 5 30 COOH NH2 




538 MEMA A-H DEAEMA 55 5 40 COOH NH2 
539 MEMA A-H DEAEMA 50 5 45 COOH NH2 
540 MEMA A-H DEAEMA 75 10 15 COOH NH2 
541 MEMA A-H DEAEMA 70 10 20 COOH NH2 
542 MEMA A-H DEAEMA 65 10 25 COOH NH2 
543 MEMA A-H DEAEMA 55 10 35 COOH NH2 
544 MEMA A-H DEAEMA 50 10 40 COOH NH2 
545 MEMA A-H DEAEMA 65 15 20 COOH NH2 
546 MEMA A-H DEAEMA 60 15 25 COOH NH2 
547 MEMA A-H DEAEMA 55 15 30 COOH NH2 
548 MEMA A-H DEAEMA 50 15 35 COOH NH2 
549 MEMA A-H DEAEMA 55 20 25 COOH NH2 
550 MEMA A-H DEAEMA 50 20 30 COOH NH2 
551 MEMA A-H DEAEMA 90 5 5 COOH NH2 
552 MEMA A-H DEAEMA 80 15 5 COOH NH2 
553 MEMA A-H DEAEMA 70 25 5 COOH NH2 
554 MEMA A-H DEAEMA 60 35 5 COOH NH2 
555 MEMA A-H DEAEMA 50 45 5 COOH NH2 
556 MEMA A-H DEAEMA 50 40 10 COOH NH2 
557 MEMA A-H DEAEMA 60 25 15 COOH NH2 
558 MEMA A-H DEAEMA 50 35 15 COOH NH2 
559 MEMA A-H DEAEMA 60 20 20 COOH NH2 
560 MEMA A-H DEAEMA 50 30 20 COOH NH2 













Peg   poly(ethylene glycol) 
PPG  poly(propylene glycol) 
PTMG  poly(tetramethylene glycol) 
PHNAD poly[1,6-hexanediol/neopentyl glycol-alt-adipic acid] diol  




BICH  1,3-bis(isocyanoatomethyl)cyclohexane 
MDI  4,4’-methylenebis(phenylisocyanate) 
HDI  1,6-diisocyanohexane 




PDI  1,4-diisocyanobenzene 
TDI  4-methyl-1,3-phenylene diisocyanate 
 
Chain Extender (Ext.): 
ED  ethylene diamine 
BD 1,4-butanediol 
EG ethylene glycol 
PG   propylene glycol 
DMAPD  3-dimethylamino-1,2-propanediol 
DEAPD 3-diethylamino-1,2-propanediol 

















Table 2: List of polyurethanes in the polyurethane library used. 
Polyurerthane 
ID number 
Polymer structure Monomer Ratios [mol] 
Diol Mn DIS Extender M 1 M 2 
1 PEG 2000 HDI - 48,5 51,5 
1 PEG 2000 HDI - 48,5 51,5 
2 PEG 900 HDI - 48,5 51,5 
3 PEG 400 HDI - 48,5 51,5 
4 PPG 2000 HDI - 48,5 51,5 
5 PTMG 2000 HDI - 48,5 51,5 
5 PTMG 2000 HDI - 48,5 51,5 
6 PEG 2000 BICH - 48,5 51,5 
7 PEG 900 BICH - 48,5 51,5 
8 PEG 400 BICH - 48,5 51,5 
8 PEG 400 BICH - 48,5 51,5 
8 PEG 400 BICH - 48,5 51,5 
9 PPG 2000 BICH - 48,5 51,5 
10 PTMG 2000 BICH - 48,5 51,5 
11 PEG 2000 TDI - 48,5 51,5 
12 PEG 900 TDI - 48,5 51,5 
13 PEG 400 TDI - 48,5 51,5 
13 PEG 400 TDI - 48,5 51,5 
14 PPG 2000 TDI - 48,5 51,5 
15 PTMG 2000 TDI - 48,5 51,5 
15 PTMG 2000 TDI - 48,5 51,5 
16 PEG 2000 MDI - 48,5 51,5 
17 PEG 900 MDI - 48,5 51,5 




18 PEG 400 MDI - 48,5 51,5 
18 PEG 400 MDI - 48,5 51,5 
19 PPG 2000 MDI - 48,5 51,5 
19 PPG 2000 MDI - 48,5 51,5 
20 PTMG 2000 MDI - 48,5 51,5 
20 PTMG 2000 MDI - 48,5 51,5 
21 PEG 2000 PDI - 48,5 51,5 
22 PEG 900 PDI - 48,5 51,5 
23 PEG 400 PDI - 48,5 51,5 
24 PPG 2000 PDI - 48,5 51,5 
25 PTMG 2000 PDI - 48,5 51,5 
26 PEG 2000 HMDI - 48,5 51,5 
26 PEG 2000 HMDI - 48,5 51,5 
27 PEG 900 HMDI - 48,5 51,5 
28 PEG 400 HMDI - 48,5 51,5 
29 PPG 2000 HMDI - 48,5 51,5 
30 PTMG 2000 HMDI - 48,5 51,5 
31 PEG 2000 HDI BD 0,25 0,52 
33 PEG 900 HDI BD 0,25 0,52 
35 PEG 400 HDI BD 0,25 0,52 
37 PPG 2000 HDI BD 0,25 0,52 
38 PPG 2000 HDI ED 0,25 0,52 
39 PTMG 2000 HDI BD 0,25 0,52 
40 PTMG 2000 HDI ED 0,25 0,52 
41 PEG 2000 BICH BD 0,25 0,52 
43 PEG 900 BICH BD 0,25 0,52 




45 PEG 400 BICH BD 0,25 0,52 
46 PEG 400 BICH ED 0,25 0,52 
47 PPG 2000 BICH BD 0,25 0,52 
48 PPG 2000 BICH ED 0,25 0,52 
49 PTMG 2000 BICH BD 0,25 0,52 
49 PTMG 2000 BICH BD 0,25 0,52 
50 PTMG 2000 BICH ED 0,25 0,52 
51 PEG 2000 TDI BD 0,25 0,52 
53 PEG 900 TDI BD 0,25 0,52 
55 PEG 400 TDI BD 0,25 0,52 
57 PPG 2000 TDI BD 0,25 0,52 
59 PTMG 2000 TDI BD 0,25 0,52 
61 PEG 2000 MDI BD 0,25 0,52 
63 PEG 900 MDI BD 0,25 0,52 
65 PEG 400 MDI BD 0,25 0,52 
67 PPG 2000 MDI BD 0,25 0,52 
69 PTMG 2000 MDI BD 0,25 0,52 
71 PEG 2000 PDI BD 0,25 0,52 
73 PEG 900 PDI BD 0,25 0,52 
77 PPG 2000 PDI BD 0,25 0,52 
79 PTMG 2000 PDI BD 0,25 0,52 
81 PEG 2000 HMDI BD 0,25 0,52 
83 PEG 900 HMDI BD 0,25 0,52 
85 PEG 400 HMDI BD 0,25 0,52 
87 PPG 2000 HMDI BD 0,25 0,52 
87 PPG 2000 HMDI BD 0,25 0,52 




39DE PTMG 2000 HDI DEAPD 0,25 0,52 
39DM PTMG 2000 HDI DMAPD 0,25 0,52 
49DM PTMG 2000 BICH DMAPD 0,25 0,52 
49DE PTMG 2000 BICH DEAPD 0,25 0,52 
91 PTMG 650 HDI BD 0,485 0,515 
92 PTMG 1000 HDI BD 0,485 0,515 
93 PTMG 650 BICH BD 0,485 0,515 
94 PTMG 1000 BICH BD 0,485 0,515 
94 PTMG 1000 BICH BD 0,485 0,515 
95 PTMG 650 MDI BD 0,485 0,515 
95 PTMG 650 MDI BD 0,485 0,515 
96 PTMG 1000 MDI BD 0,485 0,515 
97 PHNGAD 1800 BICH DMAPD 0,25 0,52 
98 PHNGAD 1800 BICH DEAPD 0,25 0,52 
99 PTMG 650 HDI DMAPD 0,25 0,52 
100 PTMG 1000 HDI DMAPD 0,25 0,52 
100 PTMG 1000 HDI DMAPD 0,25 0,52 
101 PTMG 650 BICH DMAPD 0,25 0,52 
102 PTMG 1000 BICH DMAPD 0,25 0,52 
102 PTMG 1000 BICH DMAPD 0,25 0,52 
103 PHNGAD 1800 MDI DMAPD 0,25 0,52 
103 PHNGAD 1800 MDI DMAPD 0,25 0,52 
104 PHNGAD 1800 MDI DEAPD 0,25 0,52 
104 PHNGAD 1800 MDI DEAPD 0,25 0,52 
105 PHNGAD 1800 HDI DMAPD 0,25 0,52 
105 PHNGAD 1800 HDI DMAPD 0,25 0,52 




107 PTMG 650 HDI DEAPD 0,25 0,52 
108 PTMG 1000 HDI DEAPD 0,25 0,52 
109 PTMG 650 BICH DEAPD 0,25 0,52 
110 PTMG 1000 BICH DEAPD 0,25 0,52 
111 PTMG 650 MDI DEAPD 0,25 0,52 
112 PTMG 1000 MDI DEAPD 0,25 0,52 
113 PTMG 2000 MDI DEAPD 0,25 0,52 
114 PPG 425 HDI BD 0,485 0,515 
115 PPG 1000 HDI BD 0,485 0,515 
116 PPG 425 BICH BD 0,485 0,515 
117 PPG 1000 BICH BD 0,485 0,515 
118 PPG 425 MDI DMAPD 0,25 0,52 
118 PPG 425 MDI DMAPD 0,25 0,52 
119 PPG 1000 MDI DMAPD 0,25 0,52 
120 PPG 425 BICH DEAPD 0,25 0,52 
121 PPG 1000 BICH DEAPD 0,25 0,52 
122 PPG 2000 BICH DEAPD 0,25 0,52 
123 PPG 2000 MDI DMAPD 0,25 0,52 
123 PPG 2000 MDI DMAPD 0,25 0,52 
124 PPG 2000 TDI DMAPD 0,25 0,52 
125 PPG 1000 TDI DMAPD 0,25 0,52 
125 PPG 1000 TDI DMAPD 0,25 0,52 
126 PPG 425 TDI DMAPD 0,25 0,52 
127 PPG 1000 BICH DMAPD 0,25 0,52 
128 PPG 2000 BICH DMAPD 0,25 0,52 
129 PPG 425 BICH DMAPD 0,25 0,52 




131 PTMG 1000 TDI DMAPD 0,25 0,52 
132 PHNGAD 1800 BICH BD 0,25 0,52 
132 PHNGAD 1800 BICH BD 0,25 0,52 
133 PHNGAD 1800 HDI BD 0,25 0,52 
134 PHNGAD 1800 MDI BD 0,25 0,52 
134 PHNGAD 1800 MDI BD 0,25 0,52 
135 PTMG 250 BICH DMAPD 0,25 0,52 
136 PTMG 250 BICH DEAPD 0,25 0,52 
137 PTMG 250 BICH BD 0,25 0,52 
138 PTMG 250 BICH EG 0,25 0,52 
139 PTMG 650 BICH EG 0,25 0,52 
140 PTMG 1000 BICH EG 0,25 0,52 
141 PTMG 2000 BICH EG 0,25 0,52 
142 PTMG 250 BICH PG 0,25 0,52 
143 PTMG 650 BICH PG 0,25 0,52 
144 PTMG 1000 BICH PG 0,25 0,52 
145 PTMG 2000 BICH PG 0,25 0,52 
146 PTMG 250 HDI DMAPD 0,25 0,52 
147 PTMG 250 HDI DEAPD 0,25 0,52 
148 PTMG 250 HDI BD 0,25 0,52 
149 PTMG 250 HDI EG 0,25 0,52 
150 PTMG 650 HDI EG 0,25 0,52 
151 PTMG 1000 HDI EG 0,25 0,52 
152 PTMG 2000 HDI EG 0,25 0,52 
153 PTMG 250 HDI PG 0,25 0,52 
154 PTMG 650 HDI PG 0,25 0,52 




156 PTMG 2000 HDI PG 0,25 0,52 
157 PTMG 250 MDI DMAPD 0,25 0,52 
158 PTMG 250 MDI OFHD 0,25 0,52 
159 PTMG 250 MDI BD 0,25 0,52 
160 PTMG 250 MDI EG 0,25 0,52 
161 PTMG 650 MDI EG 0,25 0,52 
162 PTMG 1000 MDI EG 0,25 0,52 
163 PTMG 2000 MDI EG 0,25 0,52 
164 PTMG 250 MDI PG 0,25 0,52 
165 PTMG 650 MDI PG 0,25 0,52 
166 PTMG 1000 MDI PG 0,25 0,52 
167 PTMG 2000 MDI PG 0,25 0,52 
168 PTMG 250 BICH none 48,5 51,5 
169 PTMG 650 BICH none 48,5 51,5 
170 PTMG 1000 BICH none 48,5 51,5 
171 PTMG 250 HDI none 48,5 51,5 
172 PTMG 650 HDI none 48,5 51,5 
173 PTMG 1000 HDI none 48,5 51,5 
174 PTMG 250 MDI none 48,5 51,5 
175 PTMG 650 MDI none 48,5 51,5 
176 PTMG 1000 MDI none 48,5 51,5 
177 PTMG 250 HDI NMPD 0,25 0,52 
178 PTMG 1000 HDI NMPD 0,25 0,52 
179 PTMG 2000 HDI NMPD 0,25 0,52 
180 PTMG 1000 BICH NMPD 0,25 0,52 
181 PTMG 2000 BICH NMPD 0,25 0,52 




183 PTMG 1000 MDI NMPD 0,25 0,52 
184 PTMG 2000 MDI NMPD 0,25 0,52 
185 PHNAD 900 MDI OFHD 0,17 0,52 
185 PHNAD 900 MDI OFHD 0,17 0,52 
186 PTMG 650 BICH OFHD 0,25 0,52 
187 PTMG 1000 BICH OFHD 0,25 0,52 
188 PTMG 2000 BICH OFHD 0,25 0,52 
189 PPG 1000 BICH OFHD 0,17 0,52 
190 PTMG 650 HDI OFHD 0,25 0,52 
190 PTMG 650 HDI OFHD 0,25 0,52 
191 PTMG 1000 HDI OFHD 0,25 0,52 
192 PTMG 2000 HDI OFHD 0,25 0,52 
193 PPG 1000 MDI DMAPD 0,17 0,52 
194 PTMG 650 MDI OFHD 0,25 0,52 
195 PTMG 1000 MDI OFHD 0,25 0,52 
196 PTMG 2000 MDI OFHD 0,25 0,52 
197 PTMG 650 BICH DHM 0,25 0,52 
198 PTMG 1000 BICH DHM 0,25 0,52 
199 PTMG 2000 BICH DHM 0,25 0,52 
200 PTMG 650 HDI DHM 0,25 0,52 
201 PTMG 1000 HDI DHM 0,25 0,52 
202 PTMG 2000 HDI DHM 0,25 0,52 
203 PTMG 650 MDI DHM 0,25 0,52 
204 PTMG 1000 MDI DHM 0,25 0,52 
205 PTMG 2000 MDI DHM 0,25 0,52 
206 PPG 1000 HDI OFHD 0,25 0,52 




208 PPG 1000 MDI OFHD 0,25 0,52 
209 PPG 1000 HDI PG 0,25 0,52 
210 PPG 1000 BICH PG 0,25 0,52 
211 PPG 1000 MDI PG 0,25 0,52 
212 PHNAD 900 HDI PG 0,25 0,52 
213 PHNAD 900 BICH PG 0,25 0,52 
214 PHNAD 900 MDI PG 0,25 0,52 
215 PHNAD 900 HDI BD 0,25 0,52 
216 PHNAD 900 BICH BD 0,25 0,52 
217 PHNAD 900 MDI BD 0,25 0,52 
218 PHNAD 900 HDI DMAPD 0,25 0,52 
219 PHNAD 900 BICH DMAPD 0,25 0,52 
220 PHNAD 900 MDI DMAPD 0,25 0,52 
220 PHNAD 900 MDI DMAPD 0,25 0,52 
221 PHNAD 900 HDI OFHD 0,25 0,52 
222 PHNAD 900 BICH OFHD 0,25 0,52 
223 PHNAD 900 MDI OFHD 0,25 0,52 
223 PHNAD 900 MDI OFHD 0,25 0,52 
224 PHNAD 900 HDI none 48,5 51,5 
225 PHNAD 900 BICH none 48,5 51,5 
226 PHNAD 900 MDI none 48,5 51,5 
227 PPG-PEG 1900 HDI none 48,5 51,5 
228 PPG-PEG 1900 BICH none 48,5 51,5 
229 PPG-PEG 1900 MDI none 48,5 51,5 
230 PPG-PEG 1900 HDI BD 0,25 0,52 
231 PPG-PEG 1900 BICH BD 0,25 0,52 




232 PPG-PEG 1900 MDI BD 0,25 0,52 
233 PPG-PEG 1900 HDI OFHD 0,25 0,52 
234 PPG-PEG 1900 BICH OFHD 0,25 0,52 
235 PPG-PEG 1900 MDI OFHD 0,25 0,52 
236 PPG-PEG 1900 HDI PG 0,25 0,52 
237 PPG-PEG 1900 BICH PG 0,25 0,52 
238 PPG-PEG 1900 MDI PG 0,25 0,52 
239 PPG-PEG 1900 HDI DMAPD 0,25 0,52 
240 PPG-PEG 1900 BICH DMAPD 0,25 0,52 
241 PPG-PEG 1900 MDI DMAPD 0,25 0,52 
242 PPG-PEG 1900 HDI EG 0,25 0,52 
243 PPG-PEG 1900 BICH EG 0,25 0,52 
244 PPG-PEG 1900 MDI EG 0,25 0,52 
245 PHNGAD 1800 HDI OFHD 0,25 0,52 
246 PHNGAD 1800 BICH OFHD 0,25 0,52 
247 PHNGAD 1800 MDI OFHD 0,25 0,52 
248 PHNGAD 1800 BICH DMAPD 0,25 0,52 
249 PHNGAD 1800 HDI none 48,5 51,5 
250 PHNGAD 1800 BICH none 48,5 51,5 
251 PHNGAD 1800 MDI none 48,5 51,5 
252 PHNGAD 1800 HDI DHM 0,25 0,52 
253 PPG-PEG 1900 MDI DMAPD 0,17 0,52 
254 PHNGAD 1800 BICH BD 0,17 0,52 
255 PPG-PEG 1900 MDI BD 0,17 0,52 
256 PPG 425 MDI none 48,5 51,5 
256 PPG 425 MDI none 48,5 51,5 




258 PTMG 1000 BICH OFHD 0,17 0,52 
259 PTMG 2000 BICH DMAPD 0,17 0,52 
260 PTMG 2000 BICH OFHD 0,17 0,52 
261 PTMG 1000 BICH BD 0,17 0,52 
262 PTMG 2000 BICH BD 0,17 0,52 
263 PTMG 1000 HDI OFHD 0,17 0,52 
264 PTMG 1000 HDI DMAPD 0,17 0,52 
265 PPG-PEG 1900 BICH OFHD 0,17 0,52 
266 PPG-PEG 1900 BICH DMAPD 0,17 0,52 
267 PPG-PEG 1900 BICH BD 0,17 0,52 
268 PTMG 1000 MDI DMAPD 0,25 0,52 
269 PPG  2000 MDI DEAPD 0,25 0,52 
270 PTMG 2000 MDI DMAPD 0,25 0,52 
271 PEG 400 MDI DMAPD 0,25 0,52 
272 PEG 400 MDI none 0,58 0,42 
273 PPG 425 MDI DMAPD 0,25 0,52 
274 PPG 425 MDI none 48,5 51,5 
275 PEG 400 MDI none 48,5 51,5 
276 PTMG 1000 MDI OFHD 0,17 0,52 
277 PTMG 2000 MDI OFHD 0,17 0,52 
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